☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended ~~March~~December 3131, 2020

☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ____________ to ____________.

(Former name, former address, and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

On ~~April 27, 2020,~~January 22, 2021, there were ~~13,866,811~~13,866,913 shares of Registrant’s class A nonvoting common stock issued and ~~12,964,117~~12,996,916 shares of Registrant’s class A nonvoting common stock issued and outstanding; no shares of Registrant’s class B nonvoting common shares outstanding; and ~~2,068,737~~2,068,635 shares of Registrant’s class C voting common stock issued and outstanding.

Assets	March 31, 2020			June 30, 2019			December 31, 2020			June 30, 2020
(dollars in thousands)	(unaudited)						(unaudited)
Current Assets
Cash and cash equivalents	$	2,086		$	1,466		$	21,619		$	1,936
Restricted cash		1,025			1,025			1,000			1,025
Investments in securities at fair value		6,313			8,021			6,331			6,322
Accounts and other receivables		399			309			2,073			974
Note receivable		-			199
Prepaid expenses		310			293			400			285
Total assets held related to discontinued operations		-			1,780
Total Current Assets		10,133			13,093			31,423			10,542

Net Property and Equipment		1,556			1,708			1,424			1,506

Other Assets
Investments in securities at fair value, non-current		3,167			7,166			6,163			5,142
Other investments		1,518			1,404			1,385			1,283
Held-to-maturity investments								1,000			-
Equity method investments		150			309			654			158
Right of use assets		105			-			68			93
Other assets, non-current		90			64			94			92
Total Other Assets		5,030			8,943			9,364			6,768
Total Assets	$	16,719		$	23,744		$	42,211		$	18,816
Liabilities and Shareholders’ Equity
Current Liabilities
Accounts payable	$	36		$	31		$	136		$	29
Accrued compensation and related costs		269			311			490			360
Dividends payable		113			113			113			113
Lease liability, short-term		49			-			51			50
Other accrued expenses		885			496			1,244			1,015
Total liabilities held related to discontinued operations		-			481
Taxes payable								4,060			-
Note payable, current								-			442
Total Current Liabilities		1,352			1,432			6,094			2,009

Long-Term Liabilities
Deferred tax liability		-			133			988			-
Lease liability, long-term		56			-			17			43
Total Long-Term Liabilities		56			133			1,005			43
Total Liabilities		1,408			1,565			7,099			2,052

Commitments and Contingencies (Note 14)
Commitments and Contingencies (Note 13)

Shareholders’ Equity
Common stock (class A) - $0.025 par value; nonvoting; authorized, 28,000,000 shares; issued, 13,866,811 shares and 13,866,751 shares at March 31, 2020, and June 30, 2019, respectively		347			347
Common stock (class A) - $0.025 par value; nonvoting; authorized, 28,000,000 shares; issued, 13,866,913 shares at December 31, 2020, and June 30, 2020								347			347
Common stock (class B) - $0.025 par value; nonvoting; authorized, 4,500,000 shares; no shares issued		-			-			-			-
Convertible common stock (class C) - $0.025 par value; voting; authorized, 3,500,000 shares; issued, 2,068,737 shares and 2,068,797 shares at March 31, 2020, and June 30, 2019, respectively		52			52
Convertible common stock (class C) - $0.025 par value; voting; authorized, 3,500,000 shares; issued, 2,068,635 shares at December 31, 2020, and June 30, 2020								52			52
Additional paid-in-capital		15,636			15,646			15,627			15,623
Treasury stock, class A shares at cost; 873,793 shares and 804,959 shares at March 31, 2020, and June 30, 2019, respectively		(1,953	)		(1,888	)
Treasury stock, class A shares at cost; 863,653 shares and 855,432 shares at December 31, 2020, and June 30, 2020, respectively								(1,925	)		(1,879	)
Accumulated other comprehensive income (loss), net of tax		(9	)		(206	)		8			(4	)
Retained earnings		1,238			7,761			21,003			2,625
Total U.S. Global Investors Inc. Shareholders’ Equity		15,311			21,712
Non-Controlling Interest in Subsidiary		-			467
Total Shareholders’ Equity		15,311			22,179			35,112			16,764
Total Liabilities and Shareholders’ Equity	$	16,719		$	23,744		$	42,211		$	18,816

The accompanying notes are an integral part of these consolidated financial statements.

	Nine Months Ended March 31,						Three Months Ended March 31,						Six Months Ended December 31,					Three Months Ended December 31,
(dollars in thousands, except per share data)	2020			2019			2020			2019			2020		2019			2020		2019
Operating Revenues
Advisory fees	$	2,477		$	2,553		$	875		$	812		$	7,864	$	1,602		$	4,669	$	842
Administrative services fees		128			141			39			45			102		89			52		45
Other operating revenue														444		-			444		-
		2,605			2,694			914			857			8,410		1,691			5,165		887
Operating Expenses
Employee compensation and benefits		2,060			2,150			715			680			4,200		1,345			3,238		633
General and administrative		2,440			2,234			1,091			753			2,538		1,349			1,292		663
Advertising		111			122			37			42			118		74			67		51
Depreciation and amortization		152			164			50			54			98		102			49		51
		4,763			4,670			1,893			1,529			6,954		2,870			4,646		1,398
Operating Loss		(2,158	)		(1,976	)		(979	)		(672	)
Operating Income (Loss)														1,456		(1,179	)		519		(511	)
Other Income (Loss)
Investment income (loss)		(3,922	)		(2,231	)		(441	)		2,100			21,700		(3,481	)		20,702		(451	)
Income (loss) from equity method investments		(146	)		(52	)		(91	)		3			484		(55	)		463		(28	)
Other income		90			27			29			7			59		61			41		39
		(3,978	)		(2,256	)		(503	)		2,110			22,243		(3,475	)		21,206		(440	)
Income (Loss) from Continuing Operations Before Income Taxes		(6,136	)		(4,232	)		(1,482	)		1,438			23,699		(4,654	)		21,725		(951	)
Provision for Income Taxes
Tax expense (benefit)		(174	)		(554	)		75			546			5,094		(249	)		5,064		(25	)
Income (Loss) from Continuing Operations		(5,962	)		(3,678	)		(1,557	)		892			18,605		(4,405	)		16,661		(926	)
Discontinued Operations
Income (loss) from discontinued operations of investment management services in Canada before income taxes		(338	)		149			(85	)		(185	)
Loss from discontinued operations of investment management services in Canada before income taxes														-		(253	)		-		(117	)
Tax benefit		-			-			-			(11	)		-		-			-		-
Income (Loss) from Discontinued Operations		(338	)		149			(85	)		(174	)
Loss from Discontinued Operations														-		(253	)		-		(117	)
Net Income (Loss)		(6,300	)		(3,529	)		(1,642	)		718			18,605		(4,658	)		16,661		(1,043	)
Less: Net Income (Loss) Attributable to Non-Controlling Interest from Discontinued Operations		(118	)		52			(30	)		(61	)
Less: Net Loss Attributable to Non-Controlling Interest from Discontinued Operations														-		(88	)		-		(40	)
Net Income (Loss) Attributable to U.S. Global Investors, Inc.	$	(6,182	)	$	(3,581	)	$	(1,612	)	$	779		$	18,605	$	(4,570	)	$	16,661	$	(1,003	)

Earnings Per Share Attributable to U.S. Global Investors, Inc.
Basic Net Income (Loss) per Share
Income (loss) from continuing operations	$	(0.40	)	$	(0.24	)	$	(0.11	)	$	0.06		$	1.23	$	(0.29	)	$	1.10	$	(0.06	)
Income (loss) from discontinued operations	$	(0.01	)	$	-		$	-		$	(0.01	)
Loss from discontinued operations													$	-	$	(0.01	)	$	-	$	-
Net income (loss)	$	(0.41	)	$	(0.24	)	$	(0.11	)	$	0.05		$	1.23	$	(0.30	)	$	1.10	$	(0.06	)
Diluted Net Income (Loss) per Share
Income (loss) from continuing operations	$	(0.40	)	$	(0.24	)	$	(0.11	)	$	0.06		$	1.23	$	(0.29	)	$	1.10	$	(0.06	)
Income (loss) from discontinued operations	$	(0.01	)	$	-		$	-		$	(0.01	)
Loss from discontinued operations													$	-	$	(0.01	)	$	-	$	-
Net income (loss)	$	(0.41	)	$	(0.24	)	$	(0.11	)	$	0.05		$	1.23	$	(0.30	)	$	1.10	$	(0.06	)

Basic weighted average number of common shares outstanding		15,127,118			15,141,061			15,121,950			15,132,408			15,081,544		15,129,674			15,082,539		15,129,114
Diluted weighted average number of common shares outstanding		15,127,118			15,141,061			15,121,950			15,132,408			15,081,849		15,129,674			15,082,943		15,129,114

The accompanying notes are an integral part of these consolidated financial statements.

	Nine Months Ended March 31,						Three Months Ended March 31,					Six Months Ended December 31,					Three Months Ended December 31,
(dollars in thousands)	2020			2019			2020			2019		2020		2019			2020		2019
Net Income (Loss) Attributable to U.S. Global Investors, Inc.	$	(6,182	)	$	(3,581	)	$	(1,612	)	$	779	$	18,605	$	(4,570	)	$	16,661	$	(1,003	)
Other Comprehensive Income (Loss), Net of Tax:
Foreign currency translation adjustment		311			(7	)		310			41		12		1			8		18
Comprehensive Income (Loss)		(5,871	)		(3,588	)		(1,302	)		820		18,617		(4,569	)		16,669		(985	)
Less: Comprehensive Income (Loss) Attributable to Non-Controlling Interest		114			(8	)		114			13
Less: Comprehensive Loss Attributable to Non-Controlling Interest													-		-			-		4
Comprehensive Income (Loss) Attributable to U.S. Global Investors, Inc.	$	(5,985	)	$	(3,580	)	$	(1,416	)	$	807	$	18,617	$	(4,569	)	$	16,669	$	(989	)

The accompanying notes are an integral part of these consolidated financial statements.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY(CONTINUED) (UNAUDITED)

(dollars in thousands)	Common Stock (class A)		Common Stock (class C)		Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Retained Earnings			Non-Controlling Interest			Total			Common Stock (class A)		Common Stock (class C)		Additional Paid-in Capital		Treasury Stock			Accumulated Other Comprehensive Income (Loss)		Retained Earnings			Non-Controlling Interest		Total
Balance at December 31, 2019 (13,866,811 shares of class A; 2,068,737 shares of class C)	$	347	$	52	$	15,638		$	(1,888	)	$	(205	)	$	2,964		$	379		$	17,287
Purchases of 69,420 shares of Common Stock (class A)		-		-		-			(68	)		-			-			-			(68	)
Issuance of stock under ESPP of 553 shares of Common Stock (class A)		-		-		(1	)		1			-			-			-			-
Balance at September 30, 2020 (13,866,913 shares of class A; 2,068,635 shares of class C)																							$	347	$	52	$	15,624	$	(1,879	)	$	-	$	4,456		$	-	$	18,600
Purchases of 15,096 shares of Common Stock (class A)																								-		-		-		(60	)		-		-			-		(60	)
Issuance of stock under ESPP of 308 shares of Common Stock (class A)																								-		-		1		-			-		-			-		1
Dividends declared		-		-		-			-			-			(114	)		-			(114	)		-		-		-		-			-		(114	)		-		(114	)
Stock bonuses		-		-		(1	)		2			-			-			-			1			-		-		2		14			-		-			-		16
Stock-based compensation expense		-		-		-			-			-			-			-			-			-		-		-		-			-		-			-		-
Deconsolidation of non-controlling interest		-		-		-			-			-			-			(463	)		(463	)		-		-		-		-			-		-			-		-
Other comprehensive income, net of tax		-		-		-			-			196			-			114			310			-		-		-		-			8		-			-		8
Net loss		-		-		-			-			-			(1,612	)		(30	)		(1,642	)
Balance at March 31, 2020 (13,866,811 shares of class A; 2,068,737 shares of class C)	$	347	$	52	$	15,636		$	(1,953	)	$	(9	)	$	1,238		$	-		$	15,311
Net income																								-		-		-		-			-		16,661			-		16,661
Balance at December 31, 2020 (13,866,913 shares of class A; 2,068,635 shares of class C)																							$	347	$	52	$	15,627	$	(1,925	)	$	8	$	21,003		$	-	$	35,112

The accompanying notes are an integral part of these consolidated financial statements.

	Nine Months Ended March 31,							Six Months Ended December 31,
(dollars in thousands)	2020			2019				2020			2019
Cash Flows from Operating Activities:
Net loss	$	(6,300	)	$	(3,529	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Net income (loss)								$	18,605		$	(4,658	)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:							Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		152			164				98			102
Net recognized loss on securities		-			98
Investment basis adjustment		(49	)		(19	)
Gain on disposal of Galileo		(151	)		-
Net loss from equity method investment		146			52
Net (income) loss from discontinued operations, net of tax		338			(149	)
Foreign currency transaction loss		228			22
Net recognized loss on disposal of fixed assets									7			-
Net recognized gain on securities									(15,043	)		-
Net (income) loss from equity method investment									(484	)		55
Net loss from discontinued operations, net of tax									-			253
Provision for deferred taxes		(139	)		(547	)			988			(249	)
Stock bonuses		3			3				18			2
Stock-based compensation expense		-			2
PPP loan forgiveness									(444	)		-
Changes in operating assets and liabilities:
Accounts receivable and notes receivable		108			671				(1,099	)		2
Prepaid expenses and other assets		(148	)		(25	)			(93	)		(207	)
Investment securities		5,707			2,902				(6,460	)		5,064
Accounts payable and accrued expenses		456			(452	)			4,503			180
Total adjustments		6,651			2,722				(18,009	)		5,202
Net cash provided by (used in) operating activities		351			(807	)
Net cash provided by operating activities									596			544
Cash Flows from Investing Activities:
Purchase of property and equipment									(23	)		-
Purchase of investments in securities at fair value, non-current		-			(1,588	)			(135	)		-
Purchase of equity method investment		-			(230	)
Purchase of other investments		(75	)		(100	)			(224	)		-
Proceeds from sale of Galileo		746			-
Proceeds on sale of equity method investment		-			230
Proceeds from note receivable		-			18
Purchase of held-to-maturity investments									(1,000	)		-
Proceeds on sale of non-current investments									20,720			-
Return of capital on investments		10			68				10			17
Net cash provided by (used in) investing activities		681			(1,602	)
Net cash provided by investing activities									19,348			17
Cash Flows from Financing Activities:
Issuance of common stock		2			3				2			2
Repurchases of common stock		(74	)		(24	)			(62	)		(6	)
Dividends paid		(340	)		(341	)			(226	)		(227	)
Net cash used in financing activities		(412	)		(362	)			(286	)		(231	)
Net increase (decrease) in cash, cash equivalents, and restricted cash		620			(2,771	)
Net increase in cash, cash equivalents, and restricted cash									19,658			330
Beginning cash, cash equivalents, and restricted cash		2,491			5,766				2,961			2,491
Ending cash, cash equivalents, and restricted cash	$	3,111		$	2,995			$	22,619		$	2,821

Supplemental Disclosures of Cash Flow Information
Cash paid for income taxes	$	-		$	119			$	2		$	-

The accompanying notes are an integral part of these consolidated financial statements.

U.S. Global Investors, Inc. (the “Company” or “U.S. Global”) has prepared the consolidated financial statements pursuant to accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the United States Securities and Exchange Commission (“SEC”) that permit reduced disclosure for interim periods. The financial information included herein reflects all adjustments (consisting solely of normal recurring adjustments), which are, in management’s opinion, necessary for a fair presentation of results for the interim periods presented. The Company has consistently followed the accounting policies set forth in the notes to the consolidated financial statements in the Company’s Form 10-K for the fiscal year ended June 30, ~~2019, except for the adoption of new accounting pronouncements discussed below.~~2020.

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, U.S. Global Investors (Bermuda) Limited, U.S. Global Investors (Canada) Limited (“USCAN”), and U.S. Global Indices, LLC, and its 65 percent interest in Galileo Global Equity Advisors Inc. (“Galileo”). through March 2, 2020.

Effective March 2, 2020, the Company sold its shares in Galileo back to Galileo. Through the date of sale, Galileo was consolidated with the operations of the Company. ~~The non-controlling interest in this subsidiary was included in “Non-Controlling Interest in Subsidiary” in the equity section of the Consolidated Balance Sheets.~~ Frank Holmes, CEO, and Lisa Callicotte, CFO, served as directors of Galileo through March 2, 2020. See Note 2 below for further information. Results of operations of Galileo through the date of sale are presented in the consolidated financial statements as discontinued operations.

Operating results for the three and nine months ended March 31, 2020, are not necessarily indicative of the results the Company may expect for the fiscal year ending June 30, 2020 (“fiscal 2020”), particularly in light of the novel coronavirus 19 (“COVID-19”) and its effects on the U.S. and global economies.

The COVID-19 pandemic presents ongoing significant economic and societal disruption and market volatility, which have known and yet to be seen impacts to the Company’s business and operating environment driven by significant volatility in the ~~interest rate and~~ financial markets. There are no reliable estimates of how long the pandemic will last, how many people are likely to be affected by it, or its impact on the overall economy.

To limit the spread of COVID-19, governments have taken various actions including the issuance of stay-at-home orders and social distancing guidelines, causing some businesses to suspend operations, disrupting the global supply chain, and creating a reduction in demand for many products. This has negatively affected global financial ~~markets and has caused significant financial market depreciation, thus reducing certain of the Company’s assets~~markets. Assets under management (“AUM”)~~, the revenue related to those assets, and returns on corporate investments. The AUM~~ are the primary source of the Company’s revenues. Revenues and net income are significantly affected by investment performance and the total value and composition of AUM. These factors, in turn, are largely determined by overall investment market performance and investor activity.

Should the negative effect on global financial markets continue for an extended period, there could be an adverse material financial impact on the Company’s results of operations, cash flows and financial position resulting from reduced revenues earned on AUM and returns on corporate investments. At this time, the Company cannot reasonably estimate the future impact, given the uncertainty over the duration and severity of the economic crisis.

There are two primary consolidation models in U.S. GAAP, the variable interest entity (“VIE”) and voting interest entity models. The Company’s evaluation for consolidation includes whether entities in which it has an interest or from which it receives fees are VIEs and whether the Company is the primary beneficiary of any VIEs identified in its analysis. A VIE is an entity in which either (a) the equity investment at risk is not sufficient to permit the entity to finance its own activities without additional financial support or (b) the group of holders of the equity investment at risk lack certain characteristics of a controlling financial interest. The primary beneficiary is the entity that has the obligation to absorb a majority of the expected losses or the right to receive the majority of the residual returns and consolidates the VIE on the basis of having a controlling financial interest.

The Company holds variable interests in, but is not deemed to be the primary beneficiary of, certain funds it advises, specifically, certain funds in U.S. Global Investors Funds (“USGIF” or the “Funds”). The Company’s interests in these VIEs consist of the Company’s direct ownership therein and any fees earned but uncollected. See further information about these funds in Notes 3 and 4. In the ordinary course of business, the Company may choose to waive certain fees or assume operating expenses of the funds it advises for competitive, regulatory or contractual reasons (see Note 4 for information regarding fee waivers). The Company has not provided financial support to any of these entities outside the ordinary course of business. The Company’s risk of loss with respect to these VIEs is limited to the carrying value of its investments in, and fees receivable from, the entities. The Company does not consolidate these VIEs because it is not the primary beneficiary. The Company’s total exposure to unconsolidated VIEs, consisting of the carrying value of investment securities and receivables for fees, was ~~$6.9~~$7.2 million at ~~March~~December 31, 2020, and ~~$8.8~~$7.0 million at June 30, ~~2019.~~2020.

Since the Company is not the primary beneficiary of the above funds it advises, the Company evaluated if it should consolidate under the voting interest entity model. Under the voting interest model, for legal entities other than partnerships, the usual condition for control is ownership, directly or indirectly, of more than 50 percent of the outstanding voting shares over an entity. The Company does not have control of any of the above funds it advises; therefore, the Company does not consolidate any of these funds.

The Company currently holds a variable interest in a fund organized as a limited partnership advised by Galileo, ~~and during fiscal years 2019 held a variable interest in another fund advised by Galileo,~~ but ~~these entities do~~this entity does not qualify as ~~VIEs.~~a VIE. Since ~~they are~~it is not ~~VIEs,~~a VIE, the Company evaluated if it should consolidate ~~them~~it under the voting interest entity model. Under the voting interest model, for legal entities other than partnerships, the usual condition for control is ownership, directly or indirectly, of more than 50 percent of the outstanding voting shares over an entity. The Company does not have control of the ~~entities~~entity and therefore, does not consolidate ~~them.~~it. However, the Company was considered to have the ability to exercise significant influence. Thus, the ~~investments have~~investment has been accounted for under the equity method of accounting. See further information about ~~these investments~~this investment in Note 3.

All significant intercompany balances and transactions have been eliminated in consolidation. Certain amounts have been reclassified for comparative purposes. Certain quarterly amounts may not add to the year-to-date amount due to rounding. The results of operations for the ~~nine~~six months ended ~~March~~December 31, 2020, are not necessarily indicative of the results ~~to be expected~~the Company may expect for the ~~entire year.~~fiscal year ending June 30, 2021 (“fiscal 2021”), particularly in light of the novel coronavirus 19 (“COVID-19”) and its effects on the U.S. and global economies.

The unaudited interim financial information in these condensed financial statements should be read in conjunction with the consolidated financial statements contained in the Company’s annual report.

~~In February 2016, the FASB issued ASU 2016-02,~~ ~~Leases~~, and has subsequently issued several amendments (collectively, “ASU 2016-02”), which replaces existing lease accounting guidance. ASU 2016-02 introduces a lessee model that brings most leases on the balance sheet by recording a lease asset and a lease liability. The new standard also requires enhanced disclosure surrounding the amount, timing and uncertainty of cash flows arising from leasing agreements. The new guidance was effective for public business entities for annual periods beginning after December 15, 2018, and interim periods therein. The Company elected the transition method at the adoption date of July 1, 2019, whereby it initially applied the new standard at the adoption date, versus at the beginning of the earliest period presented. Upon adoption, the Company elected the package of transition practical expedients which would allow the Company to carry forward prior conclusions related to: (i) whether any expired or existing contracts are or contain leases, (ii) the lease classification for any expired or existing leases and (iii) initial direct costs for existing leases. Additionally, the Company elected the practical expedient to not separate lease components from nonlease components for all except real estate leases. The Company made an accounting policy election to keep leases with an initial term of 12 months or less off the Consolidated Balance Sheets and will recognize related lease payments in the Consolidated Statements of Operations on a straight-line basis over the lease term. The Company’s current leases are primarily for equipment and for office space for the Canadian subsidiary. The adoption resulted in a gross up in total assets and total liabilities on the Company’s Consolidated Balance Sheets. Upon adoption on July 1, 2019, the Company's total assets and total liabilities increased by less than $400,000.

~~In February 2018, the FASB issued ASU 2018-02,~~ ~~Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income~~ (“ASU 2018-02”). ASU 2018-02 allowed entities the option to reclassify tax effects resulting from recording the effects of the Tax Cuts and Jobs Act enacted in December 2017 from accumulated other comprehensive income to retained earnings. The guidance was effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company adopted this standard on July 1, 2019, with no impact on its consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments, and has subsequently issued several amendments (collectively, “ASU 2016-13”). ASU 2016-13 adds to U.S. GAAP an impairment model (known as the current expected credit loss model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses. ASU 2016-13 will be effective for smaller reporting companies, including U.S. Global, for fiscal years beginning after December 15, 2022. Earlier application is permitted only for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements.

In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (“ASU 2019-04”). ASU 2019-04 clarifies areas of guidance related to the recently issued standards on credit losses (Topic 326), derivatives and hedging (Topic 815), and recognition and measurement of financial instruments (Topic 825). The standard follows the effective dates of the previously issued ASUs, unless an entity has already early adopted the previous ASUs, in which case the effective date will vary according to each specific ASU adoption. The new guidance in ASU 2019-04 on recognizing and measuring financial instruments will be effective for smaller reporting companies, including U.S. Global, for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. If an entity has adopted all of the amendments to ASU 2016-01, it is permitted to early adopt the new guidance. The Company does not believe the adoption of this new amendment will have a material impact on its consolidated financial statements.

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”). ASU 2019-12 enhances and simplifies various aspects of the income tax accounting guidance. The amendments in ASU 2019-12 are effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods therein. Early adoption of the standard is permitted. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements.

As a result of the adoptions of accounting pronouncements during the current period that affected leases, the following accounting policies have been updated. For a complete listing of the Company's significant accounting policies, please refer to the Annual Report on Form 10-K for the year ended June 30, 2019.

~~Leases~~. The Company and its subsidiaries lease equipment and office space under various leasing arrangements. Leases may be classified as either financing leases or operating leases, as appropriate. The Company determines if a contract is a lease or contains a lease at inception. The Company accounts for its office facility leases as operating leases, which may include escalation clauses. The Company accounts for lease and nonlease components as a single component for its leases, except for real estate leases. The Company elected the short-term lease exception for leases with an initial term of 12 months or less. Consequently, such leases are not recorded on the Consolidated Balance Sheets. The Company’s lease terms include options to extend or terminate the lease when it is reasonably certain they will be exercised or not, respectively.

Fixed lease payments are included in right of use (“ROU”) assets and lease liabilities within other assets and liabilities, respectively, on the Consolidated Balance Sheets. ROU assets and lease liabilities are recognized based on the present value of the future lease payments over the lease term at the commencement date using the Company’s incremental borrowing rate as the discount rate. Fixed lease payments made over the lease term are recorded as lease expense on a straight-line basis. Variable lease payments based on usage, changes in an index or market rate are expensed as incurred.

Upon adoption of ASU 2016-02, for existing leases, the Company elected to determine the discount rate based on the remaining lease term as of July 1, 2019. For new leases, the discount rates are based on the entire noncancelable lease term.

The Company is the lessor of certain areas of its owned office building under operating leases. The Company determines if a contract is a lease or contains a lease at inception. The Company elected not to separate lease and related non-lease components and account for the combined component as an operating lease.

USCAN entered into a binding letter of intent dated December 30, 2019, with Galileo whereby Galileo, pursuant to a capital restructuring, agreed to repurchase all of its common shares owned by USCAN for $1.0 million (Canadian). The transaction was subject to the approval of Canadian securities regulatory authorities and to the satisfaction of other closing conditions. The transaction closed effective March 2, 2020. Proceeds of approximately $746,000 were received (the equivalent of $1.0 million Canadian on the closing date of sale), and a realized gain of approximately $151,000 was recorded. In addition, approximately $228,000 in foreign currency loss was released from accumulated other comprehensive income (loss) into ~~current~~fiscal year 2020 loss upon closing the sale.

After the transaction, the Company has not and will not have continuing involvement with the operations of Galileo, except for an equity method investment in a fund managed by Galileo. See further information on this equity method investment in Note 3, Investments.

The results of Galileo through the March 2, 2020, closing date are reflected as “discontinued operations” in the Consolidated Statements of Operations and are therefore, excluded from continuing operations results. Comparative periods shown in the Consolidated Financial Statements have been adjusted to conform to this presentation. Operations of Galileo had previously been presented as the separate business segment of Investment Management Services – Canada.

~~The components of~~There were no assets ~~and~~or liabilities classified as discontinued operations ~~were as follows:~~at December 31, 2020, or June 30, 2020.

The components of income (loss) from discontinued operations were as follows. Note that are no amounts in the current fiscal year ~~are through~~as the sale closed March 2, ~~2020, closing date of sale.~~2020.

	Nine Months Ended March 31,					Three Months Ended March 31,						Six Months Ended December 31,					Three Months Ended December 31,
(dollars in thousands)	2020			2019		2020			2019			2020		2019			2020		2019
Revenues
Advisory fees	$	235		$	1,299	$	50		$	114		$	-	$	185		$	-	$	85
		235			1,299		50			114
Expenses
Employee compensation and benefits		77			395		23			94			-		54			-		26
General and administrative		508			810		125			229			-		383			-		166
Depreciation and amortization		6			7		1			2			-		5			-		3
		591			1,212		149			325			-		442			-		195
Other Income (Loss)
Investment income (loss)		24			23		21			(7	)		-		3			-		(7	)
Other income (loss)		(6	)		39		(7	)		33
Other income													-		1			-		-
		18			62		14			26			-		4			-		(7	)
Income (loss) from discontinued operations of investment management services in Canada before income taxes		(338	)		149		(85	)		(185	)
Tax benefit		-			-		-			(11	)
Income (loss) from discontinued operations of investment management services in Canada		(338	)		149		(85	)		(174	)
Less: net income (loss) attributable to non-controlling interest from discontinued operations		(118	)		52		(30	)		(61	)
Net income (loss) attributable to U.S. Global Investors, Inc. from discontinued operations of investment management services in Canada	$	(220	)	$	97	$	(55	)	$	(113	)
Loss from discontinued operations of investment management services in Canada before income taxes													-		(253	)		-		(117	)
Tax expense (benefit)													-		-			-		-
Loss from discontinued operations of investment management services in Canada													-		(253	)		-		(117	)
Less: net loss attributable to non-controlling interest from discontinued operations													-		(88	)		-		(40	)
Net loss attributable to U.S. Global Investors, Inc. from discontinued operations of investment management services in Canada												$	-	$	(165	)	$	-	$	(77	)

Galileo provides advisory services for clients in Canada and receives advisory fees based on the net asset values of the clients. Galileo may also receive performance fees from certain clients when market appreciation or realized net gains exceeds established benchmarks. Performance fees, which were included in advisory fees in the table above if applicable, were recognized when it was determined that they were no longer probable of significant reversal. Galileo recorded no performance fees from these clients for the three or nine months ended March 31, 2020, or the three months ended March 31, 2019. Galileo recorded performance fees of $870,000 for the nine months ended March 31, 2019. Prior to November 2018, performance fees were typically recognized on an annual basis at calendar year-end. Due to changes in ~~funds managed and new agreements in the second quarter of~~ fiscal year ~~2019, the recognition of these fees changed to a quarterly basis.~~2020. Galileo may, at its discretion, waive and absorb some of its clients’ operating expenses. The amount of fund expenses waived and absorbed (recovered) was ~~$19,000~~($20,000) and ~~$39,000 for~~$20,000 the three and ~~nine~~six months ended ~~March 31, 2020, and $66,000 and $227,000 for the three and nine months ended March~~December 31, 2019, respectively.

Galileo had leases for office equipment and facilities. See further information on these leases in Note 7,6, Leases.

Galileo files a separate tax return in Canada. At June 30, 2019, a valuation allowance for Galileo of $183,000 was included to fully reserve for net operating loss carryovers, other carryovers and certain book/tax differences in the balance sheet.

As of ~~March~~December 31, 2020, the Company held investments in securities at fair value totaling approximately ~~$9.5~~$12.5 million with a cost basis of approximately ~~$12.9~~$10.6 million. The fair value of these investments is ~~56.7~~29.6 percent of the Company’s total assets at ~~March~~December 31, 2020. In addition, the Company held other investments of approximately ~~$1.5~~$1.4 million, held-to-maturity debt investments of approximately $1.0 million and investments of approximately ~~$150,000~~$654,000 accounted for under the equity method of accounting.

The Company’s equity investments with readily determinable fair values are classified as securities at fair value, and changes in unrealized gains or losses are reported in current period earnings.

Held-to-maturity debt investments are purchased with the intent and ability to hold until maturity and are measured at amortized cost, which approximates fair value. The Company’s investments in held-to-maturity debt investments were $1.0 million maturing in six years, as of December 31, 2020. The Company did not have any held-to-maturity debt as of June 30, 2020.

Other investments consist of equity investments in entities over which the Company is unable to exercise significant influence and which do not have readily determinable fair values. For these securities, the Company generally elects to value using the measurement alternative, under which such securities are measured at cost, less impairment, plus or minus observable price changes for identical or similar securities of the same issuer with such changes recorded in investment income (loss). See further information about these investments in a separate section of this note.

The cost basis of investments may also be adjusted for amortization of premium or accretion of discount on debt securities held or the recharacterization of distributions from investments in partnerships.

The following details the components of the Company’s investments recorded at fair value as of ~~March~~December 31, 2020, and June 30, ~~2019.~~2020.

	March 31, 2020							December 31, 2020
(dollars in thousands)	Cost		Unrealized Gains (Losses)			Fair Value		Cost		Unrealized Gains (Losses)			Fair Value
Securities at fair value
Common stock - International	$	5,641	$	(3,034	)	$	2,607	$	3,313	$	2,036		$	5,349
Common stock - Domestic		45		(45	)		-		45		(45	)		-
Mutual funds - Fixed income		6,313		-			6,313		6,313		18			6,331
Mutual funds - Global equity									929		(115	)		814
Mutual funds - Domestic equity		929		(369	)		560		-		-			-
Total securities at fair value	$	12,928	$	(3,448	)	$	9,480	$	10,600	$	1,894		$	12,494

	June 30, 2019							June 30, 2020
(dollars in thousands)	Cost		Unrealized Gains (Losses)			Fair Value		Cost		Unrealized Gains (Losses)			Fair Value
Securities at fair value
Common stock - International	$	5,641	$	790		$	6,431	$	5,641	$	(1,162	)	$	4,479
Common stock - Domestic		45		(45	)		-		45		(45	)		-
Mutual funds - Fixed income		8,025		(4	)		8,021		6,313		9			6,322
Mutual funds - Global equity									-		-			-
Mutual funds - Domestic equity		929		(194	)		735		929		(266	)		663
Total securities at fair value	$	14,640	$	547		$	15,187	$	12,928	$	(1,464	)	$	11,464

Included in the above table was ~~$6.9~~$7.1 million and ~~$8.8~~$7.0 million as of ~~March~~December 31, 2020, and June 30, ~~2019,~~2020, respectively, at fair value invested in USGIF.

The following summarizes investment income (loss) reflected in earnings from continuing operations:

		Nine Months Ended						Three Months Ended						Six Months Ended						Three Months Ended
(dollars in thousands)		March 31,						March 31,						December 31,						December 31,
Investment Income (Loss)		2020			2019			2020			2019			2020			2019			2020		2019
Unrealized gains (losses) on fair valued securities		$	(3,995	)	$	(2,387	)	$	(342	)	$	1,987		$	6,573		$	(3,653	)	$	5,466	$	(591	)
Unrealized losses on equity securities without readily determinable fair values			-			-			(100	)		-
Unrealized gains (losses) on equity securities without readily determinable fair values															(113	)		100			-		100
Realized gains on sales of fair valued securities			-			16			-			16			15,043			-			15,043		-
Realized gain on sale of subsidiary	��		151			-			151			-
Realized foreign currency gains (losses)			(234	)		(28	)		(234	)		16
Impairments in equity securities without readily determinable fair values			-			(114	)		-			(28	)
Realized foreign currency gains															176			-			175		1
Dividend and interest income			156			282			84			109			21			72			18		39
Total Investment Income (Loss)		$	(3,922	)	$	(2,231	)	$	(441	)	$	2,100		$	21,700		$	(3,481	)	$	20,702	$	(451	)

~~Realized gain~~During the quarter ended December 31, 2020, the Company sold its 10 million common shares of HIVE Blockchain Technologies Ltd. (“HIVE”). HIVE is a company that is headquartered and traded in Canada with cryptocurrency mining facilities in Iceland, Sweden, and Canada. The cost of the 10 million shares was $2.4 million. In fiscal year 2019, the Company adopted ASU 2016-01 Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”) and its amendments. On July 1, 2018, the Company reclassified $3.2 million of unrealized gains related to its investment in HIVE from ~~sale~~Accumulated Other Comprehensive Income (Loss) into Retained Earnings. Therefore, when the HIVE investment was sold, the amount included in realized gains on sales of ~~subsidiary shown in~~fair valued securities was the ~~table above~~proceeds of $20.6 million, less the cost of $2.4 million and the ASU 2016-01 reclassified unrealized gains of $3.2 million, or $15.0 million. Frank Holmes serves on the board as non-executive chairman of HIVE and held shares and options at December 31, 2020. Effective August 31, 2018, Mr. Holmes was named Interim Executive Chairman of HIVE while a search for a new CEO is ~~from the sale of Galileo.~~undertaken. See Note 214 for ~~further information on this transaction. Realized foreign currency gains (losses) for the three and nine months ended March 31, 2020, includes $228,000~~subsequent investment in ~~foreign currency losses released from other comprehensive income (loss) upon the sale of Galileo.~~HIVE.

The three and ~~nine~~six months ended ~~March~~December 31, 2020, included approximately ~~$442,000~~$5.5 million and ~~$4.0~~$6.5 million of net unrealized ~~losses~~gains recognized on equity securities still held at ~~March~~December 31, 2020.

Investment income (loss) can be volatile and varies depending on market fluctuations, the Company’s ability to participate in investment opportunities, and timing of transactions. The Company expects that gains and losses will continue to fluctuate in the future.

ASC 820, Fair Value Measurement and Disclosures, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value and requires companies to disclose the fair value of their financial instruments according to a fair value hierarchy (i.e., Levels 1, 2, and 3 inputs, as defined below). The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.

Financial instruments measured and reported at fair value are classified and disclosed in one of the following categories:

Level 1 – Valuations based on quoted prices in active markets for identical assets or liabilities at the reporting date. Since valuations are based on quoted prices that are readily and regularly available in an active market, value of these products does not entail a significant degree of judgment.

Level 2 – Valuations based on quoted prices in markets for which not all significant inputs are observable, directly or indirectly. Corporate debt securities valued in accordance with the evaluated price supplied by an independent service are categorized as Level 2 in the hierarchy. Other securities categorized as Level 2 include securities valued at the mean between the last reported bid and ask quotation and securities valued with an adjustment to the quoted price due to restrictions.

Level 3 – Valuations based on inputs that are unobservable and significant to the fair value measurement.

The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with the investing in those securities. Because of the inherent uncertainties of valuation, the values reflected may materially differ from the values received upon actual sale of those investments.

For actively traded securities, the Company values investments using the closing price of the securities on the exchange or market on which the securities principally trade. If the security is not traded on the last business day of the quarter, it is generally valued at the mean between the last bid and ask quotation. The fair value of a security that has a restriction is based on the quoted price for an otherwise identical unrestricted instrument that trades in a public market, adjusted for the estimated effect of the restriction. Mutual funds, which include open- and closed-end funds and exchange-traded funds, are valued at net asset value or closing price, as applicable. Certain corporate debt securities not traded on an exchange may be valued by an independent pricing service using an evaluated quote based on such factors as institutional-size trading in similar groups of securities, yield, quality, maturity, coupon rate, type of issuance and individual trading characteristics and other market data. As part of its independent price verification process, a portfolio management team, which includes representatives from the investment and accounting departments, periodically reviews the fair value provided by the pricing service using information such as transactions in these investments, broker quotes, market transactions in comparable investments, general market conditions and the issuer’s financial condition. Certain debt securities may be valued based on review of similarly structured issuances in similar jurisdictions, when possible, or based on other traded debt securities issued by the issuer. The portfolio management team also takes into consideration numerous other factors that could affect valuation such as overall market conditions, liquidity of the security and bond structure. For other securities included in the fair value hierarchy with unobservable inputs, the portfolio management team considers a number of factors in determining a security’s fair value, including the security’s trading volume, market values of similar class issuances, investment personnel’s judgment regarding the market experience of the issuer, financial status of the issuer, the issuer’s management, and back testing, as appropriate. The fair values may differ from what may have been used had a broader market for these securities existed. The portfolio management team reviews inputs and assumptions and reports material items to the Board of Directors. Securities which do not have readily determinable fair values are also periodically reviewed by the portfolio management team.

The following presents fair value measurements, as of ~~March~~December 31, 2020, and June 30, ~~2019,~~2020, for the major categories of ~~U.S. Global’s~~ investments measured at fair value on a recurring basis:

	March 31, 2020								December 31, 2020
	Quoted Prices		Significant Other Inputs		Significant Unobservable Inputs				Quoted Prices		Significant Other Inputs		Significant Unobservable Inputs
(dollars in thousands)	(Level 1)		(Level 2)		(Level 3)		Total		(Level 1)		(Level 2)		(Level 3)		Total
Securities at fair value
Common stock - International	$	2,386	$	221	$	-	$	2,607	$	5,349	$	-	$	-	$	5,349
Common stock - Domestic		-		-		-		-		-		-		-		-
Mutual funds - Fixed income		6,313		-		-		6,313		6,331		-		-		6,331
Mutual funds - Global equity										814		-		-		814
Mutual funds - Domestic equity		560		-		-		560		-		-		-		-
Total securities at fair value	$	9,259	$	221	$	-	$	9,480	$	12,494	$	-	$	-	$	12,494

	June 30, 2019								June 30, 2020
	Quoted Prices		Significant Other Inputs		Significant Unobservable Inputs				Quoted Prices		Significant Other Inputs		Significant Unobservable Inputs
(dollars in thousands)	(Level 1)		(Level 2)		(Level 3)		Total		(Level 1)		(Level 2)		(Level 3)		Total
Securities at fair value
Common stock - International	$	5,599	$	832	$	-	$	6,431	$	4,447	$	32	$	-	$	4,479
Common stock - Domestic		-		-		-		-		-		-		-		-
Mutual funds - Fixed income		8,021		-		-		8,021		6,322		-		-		6,322
Mutual funds - Global equity										-		-		-		-
Mutual funds - Domestic equity		735		-		-		735		663		-		-		663
Total securities at fair value	$	14,355	$	832	$	-	$	15,187	$	11,432	$	32	$	-	$	11,464

As of ~~March~~December 31, 2020, 98and June 30, 2020, approximately 100 percent of the Company’s financial assets were classified in the fair value hierarchy as Level ~~1 and 2 percent as Level 2. As of June 30, 2019, 95 percent of the Company’s financial assets were classified in the fair value hierarchy as Level 1 and 5 percent as Level 2~~1.

The Company has an investment in 10 million common shares of HIVE Blockchain Technologies Ltd. (“HIVE”), a company that is headquartered and traded in Canada with cryptocurrency mining facilities in Iceland and Sweden, at a cost of $2.4 million. The shares are subject to Canadian securities regulations. The investment was valued at approximately $1.3 million at March 31, 2020, and $3.6 million at June 30, 2019. Cryptocurrency markets and related stocks have been, and are expected to continue to be, volatile. Cryptocurrency mining is considered an early stage high-risk industry, and the nature of mining is expected to evolve. There has been significant volatility in the market price of HIVE, which has materially impacted the investment’s value included on the balance sheet and unrealized gain (loss) recognized in investment income. The Company’s direct ownership of HIVE was approximately 3.1 percent as of March 31, 2020. Frank Holmes serves on the board as non-executive chairman of HIVE and held shares and options at March 31, 2020. Effective August 31, 2018, Mr. Holmes was named Interim Executive Chairman of HIVE while a search for a new CEO is undertaken.

The Company has an investment in Thunderbird Entertainment Group Inc. (“Thunderbird”), a company headquartered and traded in Canada, ~~which was valued~~ at ~~approximately $562,000 at March 31, 2020,~~a cost of ~~which $361,000 was classified as Level 1 and $201,000 was classified as Level 2 in the fair value hierarchy.~~$1.5 million. The investment was valued at approximately ~~$1.1~~$3.0 million and $1.2 million at December 31, 2020, and June 30, ~~2019, of which $377,000~~2020, respectively, and was classified as Level 1 ~~and $675,000 was classified as Level 2~~ in the fair value hierarchy. The portion of the investment classified in Level 2 is restricted for resale due to escrow provisions; its valuation is based on the quoted market price adjusted for the restriction on resale. The remaining shares in escrow will be released in April 2020. The shares are subject to Canadian securities regulations. The Company’s ownership of Thunderbird was approximately ~~2.5~~2.4 percent as of ~~March~~December 31, 2020. Frank Holmes serves on the board of this company as a director and held options at ~~March~~December 31, 2020.

The Company has an investment in GoldSpot Discoveries Corp. (“GoldSpot”), a technology company headquartered and traded in Canada which leverages machine learning in natural resource ~~exploration.~~exploration, at a cost of $1.5 million. The investment was valued at approximately ~~$695,000~~$2.1 million at ~~March~~December 31, 2020, ~~of which $675,000~~and was classified as Level 1 ~~and $20,000 was classified as Level 2~~ in the fair value hierarchy. The investment was valued at approximately ~~$1.7 million~~$806,000 at June 30, ~~2019,~~2020, of which ~~$1.6 million~~$774,000 was classified as Level 1 and ~~$157,000~~$32,000 was classified as Level 2 in the fair value hierarchy. The portion of the investment classified in Level 2 iswas restricted for resale due to escrow and regulatory provisions; its valuation iswas based on the quoted market price adjusted for the restriction on resale. The remaining shares in escrow ~~will be~~were released in August 2020. ~~The shares are subject to Canadian securities regulations.~~ The Company’s ownership of GoldSpot was approximately ~~7.5~~7.3 percent as of ~~March~~December 31, 2020. ~~Frank~~ Holmes ~~serves~~served on the board of this company as director from February 2019 to June 2020 and as independent chairman from February 2019 to May 2020 and held common stock and options at ~~March~~December 31, 2020.

The carrying value of equity securities without readily determinable fair values was approximately ~~$1.5~~$1.4 million and ~~$1.4~~$1.3 million as of ~~March~~December 31, 2020, and June 30, ~~2019,~~2020, respectively. The Company has elected to value these investments using the measurement alternative, under which such securities are measured at cost, less impairment, plus or minus observable price changes for identical or similar securities of the same issuer with such changes recorded in investment income (loss).

The carrying value of equity securities without readily determinable fair values has been adjusted as follows:

	Nine Months Ended						Three Months Ended						Six Months Ended						Three Months Ended
	March 31,						March 31,						December 31,						December 31,
(dollars in thousands)	2020			2019			2020			2019			2020			2019			2020			2019
Carrying amount, beginning of period	$	1,404		$	2,207		$	1,488		$	602		$	1,283		$	1,404		$	1,300		$	1,396
Adjustments:
Purchases		75			100			75			100			225			-			91			-
Reclassification to securities at fair value		-			(1,499	)		-			-
Impairments		-			(114	)		-			(28	)
Other downward adjustments		(124	)		(49	)		(108	)		(29	)		(123	)		(16	)		(6	)		(8	)
Upward adjustments		163			-			63			-			-			100			-			100
Carrying amount, end of period	$	1,518		$	645		$	1,518		$	645		$	1,385		$	1,488		$	1,385		$	1,488

Cumulative impairment adjustments to all equity securities without readily determinable fair values total ~~$251,000~~$536,000 since their respective acquisitions through ~~March~~December 31, 2020. The cumulative amount of other downward adjustments, which ~~primarily consist of~~include return of capital distributions and observable price changes, is ~~$777,000,~~$900,000, which includes ~~$108,000~~$6,000 and ~~$124,000~~$123,000 for the three and ~~nine~~six months ended ~~March~~December 31, 2020, respectively. The cumulative amount of upward adjustments is ~~$781,000~~$780,000 through ~~March~~December 31, ~~2020, which includes $63,000 and $163,000~~2020. There were no upward adjustments in the three ~~months~~ and ~~nine~~six months ended ~~March~~December 31, 2020, respectively.

Investments classified as equity method consist of investments in companies in which the Company is able to exercise significant influence but not control. Under the equity method of accounting, the investment is initially recorded at cost, then the Company’s proportional share of investee’s underlying net income or loss is recorded as a component of “other income (loss)” with a corresponding increase or decrease to the carrying value of the investment. Distributions received from the investee reduce the Company’s carrying value of the investment. These investments are evaluated for impairment if events or circumstances arise that indicate that the carrying amount of such assets may not be recoverable.

During fiscal ~~year 2018,~~years 2020 and 2021, the Company ~~through USCAN, invested approximately $401,000~~had an equity method investment in ~~the~~Galileo New Economy Fund LP (previously known as Galileo Technology and Blockchain ~~Fund,~~LP), a Canadian ~~unit trust investment fund~~limited partnership managed by Galileo. The fund reorganized in a taxable transaction into a limited partnership effective November 30, 2018, and the fund terminated. See further discussion below. During the period of ownership, the Company’s ownership ranged between approximately 20 and 25 percent, and the Company was considered to have the ability to exercise significant influence. Thus, the investment was accounted for under the equity method of accounting. Under the equity method, the Company’s proportional share of the fund’s net income or loss, which primarily consists of realized and unrealized gains and losses on investments offset by fund expenses, is recognized in the Company’s earnings. Included in other income (loss) for the nine months ended March 31, 2019, is ($50,000) of equity method loss for the Galileo Technology and Blockchain Fund. Frank Holmes also directly held an investment in the fund. This fund had a concentration in technology and blockchain companies, which resulted in volatility in the fund’s valuation.

As noted above, the Galileo Technology and Blockchain Fund reorganized into a limited partnership effective November 30, 2018. The investment portfolio and unitholders’ interests of the Galileo Technology and Blockchain Fund and the Galileo Partners Fund transferred to the new entity, named Galileo Technology and Blockchain LP. The valuation of the Company’s investment in the Galileo Technology and Blockchain Fund as of November 30, 2018, of approximately $230,000 transferred to the Galileo Technology and Blockchain LP. The Company owns approximately 2221.6 percent of the LP as of ~~March~~December 31, 2020, and the Company is considered to have the ability to exercise significant influence. Thus, the investment is accounted for under the equity method of accounting. Included in other income (loss) for the three and ~~nine~~six months ended ~~March~~December 31, 2020, is ~~($91,000)~~$463,000 and ~~($146,000)~~$484,000 of equity method ~~loss~~income for this investment. Included in other income (loss) for the three and ~~nine~~six months ended ~~March~~December 31, 2019, is ~~$3,000~~($28,000) and ($~~2,000)~~55,000) of equity method ~~income (loss)~~loss for this investment. The Company’s investment in the LP was valued at approximately ~~$150,000~~$654,000 and $158,000 at ~~March~~December 31, ~~2020.~~2020, and June 30, 2020, respectively. Frank Holmes also directly held an investment in the LP as of ~~March~~December 31, 2020. This investment has a concentration in technology and blockchain companies, which may result in volatility in its valuation.

The following table presents operating revenues disaggregated by performance obligation:

	Nine Months Ended March 31,						Three Months Ended March 31,						Six Months Ended December 31,					Three Months Ended December 31,
(dollars in thousands)	2020			2019			2020			2019			2020		2019			2020		2019
USGIF advisory fees	$	2,413		$	2,469		$	753		$	785		$	1,803	$	1,660		$	907	$	824
USGIF performance fees paid		(391	)		(372	)		(79	)		(110	)
USGIF performance fees earned (paid)														124		(312	)		115		(115	)
ETF advisory fees		455			456			201			137			5,937		254			3,647		133
Total Advisory Fees		2,477			2,553			875			812			7,864		1,602			4,669		842
USGIF administrative services fees		128			141			39			45			102		89			52		45
Other Operating Revenue														444		-			444		-
Total Operating Revenue	$	2,605		$	2,694		$	914		$	857		$	8,410	$	1,691		$	5,165	$	887

The Company serves as investment adviser to USGIF and receives a fee based on a specified percentage of average assets under management. The advisory agreement for the equity funds within USGIF provides for a base advisory fee that is adjusted upwards or downwards by 0.25 percent when there is a performance difference of 5 percent or more between a fund’s performance and that of its designated benchmark index over the prior rolling 12 months.

The Company has agreed to contractually limit the expenses of the Near-Term Tax Free Fund through April 2021. The Company has voluntarily waived or reduced its fees and/or agreed to pay expenses on the remaining USGIF funds. These caps will continue on a voluntary basis at the Company’s discretion. The aggregate fees waived and expenses borne by the Company for USGIF for the three and ~~nine~~six months ended ~~March~~December 31, 2020, were ~~$141,000~~$185,000 and ~~$407,000,~~$401,000, respectively, compared with ~~$164,000~~$122,000 and ~~$541,000,~~$266,000, respectively, for the corresponding period in the prior fiscal year. Management cannot predict the impact of future waivers due the number of variables and the range of potential outcomes.

The Company receives administrative service fees from USGIF based on ~~the~~an annual rate of 0.05 percent of average daily net assets ~~at an annual rate 0.05 percent per investor class and 0.04 percent per institutional class~~ of each fund. ~~The institutional classes closed in June 2019.~~

The Company also serves as investment advisor to two exchange-traded funds (ETFs): U.S. Global Jets ETF (ticker JETS) and U.S. Global GO GOLD and Precious Metal Miners ETF (ticker GOAU). The Company receives a unitary management fee of 0.60 percent of average net assets and has agreed to bear all expenses of the ETFs.

As of ~~March~~December 31, 2020, the Company had ~~$264,000~~$2.0 million in receivables from fund clients, of which ~~$167,000~~$394,000 was from USGIF and ~~$97,000~~$1.6 million from the ETFs. As of June 30, ~~2019,~~2020, the Company had ~~$201,000~~$869,000 in receivables from fund clients, of which ~~$159,000~~$187,000 was from USGIF and ~~$42,000~~$682,000 from the ETFs.

Other Operating revenue includes the extinguishment of debt related to the forgiveness of the Paycheck Protection Program (“PPP”) loan and accrued interest. See further information on the PPP loan in Note 7, Borrowings.

Restricted cash represents cash invested in a money market account as collateral for credit facilities that is not available for general corporate use. A reconciliation of cash, cash equivalents, and restricted cash reported from the consolidated balance sheets to the statements of cash flows is shown below:

Previously, the Company held a note receivable with an unrelated third party which had an annual interest rate of 15 percent and a stated maturity in November 2021. Interest was paid monthly. Quarterly principal repayments started in February 2019. The balance of this note was $199,000 at June 30, 2019, all of which was classified in current assets. The issuer elected an early redemption option and paid the note in full in July 2019. Proceeds were received for the principal and all accrued interest, and no gain or loss was realized.

The Company has lease agreements on a continuing operations basis for office equipment ~~and real estate in Canada~~ that expire ~~between~~in fiscal ~~years 2020 and 2023.~~year 2022. Lease expense included in continuing operations totaled ~~$39,000~~$38,000 and ~~$115,000~~$77,000 for the three and ~~nine~~six months ended ~~March~~December 31, 2020, and ~~$36,000~~$38,000 and ~~$132,000~~$76,000 for the three and ~~nine~~six months ended ~~March~~December 31, 2019, respectively.

The Company’s former subsidiary Galileo, which is classified as discontinued operations as described in Note 2, had lease agreements for office equipment and for office facilities. Lease expense included in discontinued operations totaled ~~$14,000~~$29,000 and ~~$74,000~~$60,000 for the three and ~~nine~~six months ended ~~March~~December 31, ~~2020, and $27,000 and $81,000 for the three and nine months ended March 31, 2019, respectively.~~2019.

For continuing operations, the components of lease expense included in general and administrative expense on the Consolidated Statements of Operations and qualitative information concerning the Company’s operating leases were as follows:

	Nine Months Ended			Three Months Ended		Six Months Ending						Three Months Ending
	March 31,			March 31,		December 31,						December 31,
(dollars in thousands)	2020			2020		2020			2019			2020		2019
Operating lease cost	$	39		$	13	$	26		$	26		$	13	$	13
Short-term lease cost		76			26		51			50			25		25
Total lease cost	$	115		$	39	$	77		$	76		$	38	$	38

Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$	39		$	13	$	26		$	26		$	13	$	13

Right-of-use assets obtained in exchanged for:
Net operating lease liabilities	$	141		$	-	$	-		$	141		$	-	$	-

Weighted-average remaining lease term (in years)		2.08					1.33			2.33
Weighted-average discount rate		4.11	%				4.11	%		4.11	%

Maturities of lease liabilities from continuing operations as of ~~March~~December 31, 2020, are as follows:

(dollars in thousands)
Fiscal Year	Operating Leases			Operating Leases
2020 (excluding the nine months ended March 31, 2020)	$	13
2021		53
2021 (excluding the six months ended December 31, 2020)				$	26
2022		44			44
Total lease payments		110			70
Less imputed interest		(5	)		(2	)
Total	$	105		$	68

The Company is the lessor of certain areas of its owned office building under operating leases expiring in various years through fiscal year 2023. At the commencement of an operation lease, no income is recognized; subsequently, lease payments received are recognized on a straight-line basis. Lease income included in other income on the Consolidated Statements of Operations for the three and ~~nine~~six months ~~ending March~~ended December 31, 2020, was $23,000 and ~~$64,000,~~$46,000, respectively. Lease income included in other income on the Consolidated Statements of Operations for the three and six months ended December 31, 2019, was $24,000 and $41,000, respectively. The cost of obtaining lessor contracts, which is included in other assets on the Consolidated Balance Sheets, was ~~$8,000~~$6,000 and $0$7,000 at ~~March~~December 31, 2020, and June 30, ~~2019,~~2020, respectively.

A summary analysis of annual undiscounted cash flows to be received on leases as of ~~March~~December 31, 2020, is as follows:

(dollars in thousands)
Fiscal Year	Operating Leases		Operating Leases
2020 (excluding the nine months ended March 31, 2020)	$	24
2021		97
2021 (excluding the six months ended December 31, 2020)			$	49
2022		81		81
2023		34		34
Total lease payments	$	236	$	164

The Company may terminate the building leases with one hundred eighty days written notice if it sells the property. If the Company terminates the lease, the Company will pay the tenant a termination fee of the lesser of six months of the base monthly rent or the base monthly rent times the number of months remaining in the initial term.

The Company has access to a $1 million credit facility for working capital purposes. The credit agreement requires the Company to maintain certain covenants; the Company has been in compliance with these covenants during the current fiscal year. The credit agreement will expire on May 31, ~~2020,~~2021, and the Company intends to renew annually. The credit facility is collateralized by $1 million at ~~March~~December 31, 2020, shown as restricted cash on the balance sheet, held in deposit in a money market account at the financial institution that provided the credit facility. As of ~~March~~December 31, 2020, the credit facility remains unutilized by the Company.

~~See Note 15, Subsequent Events,~~Effective April 12, 2020, the Company was approved for a ~~borrowing that was entered into subsequent to March 31, 2020.~~loan of approximately $442,000 under the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”). The Company has under 25 employees and is considered a small business.

The Company has been granted forgiveness of the entire PPP loan and any accrued interest. Included in Other Operating Revenue, the Company recognized a gain on extinguishment of debt, including interest, of $444,000.

Payment of cash dividends is within the discretion of the Company’s board of directors and is dependent on earnings, operations, capital requirements, general financial condition of the Company, and general business conditions. A monthly dividend of $0.0025 per share was paid during fiscal year ~~2019~~2020 and for July ~~2019~~2020 through ~~March~~December 2020, and as of December 31, 2020 is authorized through ~~June 2020,~~March 2021, at which time it will be considered for continuation. See Note 14 for subsequent change in monthly dividend.

The Company has a share repurchase program, approved by the Board of Directors, authorizing the Company to annually purchase up to $2.75 million of its outstanding common shares, as market and business conditions warrant, on the open market in compliance with Rule 10b-18 of the Securities Exchange Act of 1934 through December 31, ~~2020.~~2021. The repurchase program has been in place since December 2012, and the Board of Directors has annually renewed the repurchase program each calendar year. The acquired shares may be used for corporate purposes, including shares issued to employees in the Company’s stock-based compensation programs. For the three and ~~nine~~six months ended ~~March~~December 31, 2020, the Company repurchased ~~69,420~~15,000 and ~~72,820~~16,000 class A shares using cash of ~~$68,000~~$60,000 and ~~$74,000,~~$62,000, respectively. For the three and six months ended ~~March~~December 31, 2019, the Company repurchased ~~8,075~~2,000 and ~~20,075~~3,400 class A shares using cash of ~~$9,000~~$3,000 and ~~$24,000,~~$6,000, respectively.

The Company’s stock option plans provide for the granting of class A shares as either incentive or nonqualified stock options to employees and non-employee directors. Options are subject to terms and conditions determined by the Compensation Committee of the Board of Directors. There were 2,000 options outstanding and exercisable at ~~March~~December 31, 2020, at a weighted average exercise price of $2.74. There were no options granted, forfeited, or exercised for the ~~three~~six months ended ~~March~~December 31, 2020. There were 2,000 options ~~that were~~ forfeited ~~and no options granted or exercised~~ during the ~~nine~~six months ended ~~March 31, 2020. There were no options granted, exercised, or forfeited for the three or nine months ended March~~December 31, 2019.

Stock-based compensation expense is measured at the grant date based on the fair value of the award, and the cost is recognized as expense ratably over the award’s vesting period. There was no stock-based compensation expense for the three and ~~nine~~six months ended ~~March~~December 31, 2020, or ~~the three months ended March 31, 2019. Stock-based compensation expense was $2,000 for the nine months ended March 31,~~ 2019. As of ~~March~~December 31, 2020, and 2019, there was no unrecognized share-based compensation cost related to share-based awards granted under the plans.

The basic earnings per share (“EPS”) calculation excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution of EPS that could occur if options to issue common stock were exercised.

	Nine Months Ended March 31,						Three Months Ended March 31,						Six Months Ended December 31,					Three Months Ended December 31,
(dollars in thousands, except per share data)	2020			2019			2020			2019			2020		2019			2020		2019
Income (Loss) from Continuing Operations	$	(5,962	)	$	(3,678	)	$	(1,557	)	$	892		$	18,605	$	(4,405	)	$	16,661	$	(926	)
Income (Loss) from Discontinued Operations		(338	)		149			(85	)		(174	)
Less: Net Income (Loss) Attributable to Non-Controlling Interest from Discontinued Operations		(118	)		52			(30	)		(61	)
Net Income (Loss) Attributable from Discontinued Operations to U.S. Global Investors, Inc.		(220	)		97			(55	)		(113	)

Loss from Discontinued Operations														-		(253	)		-		(117	)
Less: Net Loss Attributable to Non-Controlling Interest from Discontinued Operations														-		(88	)		-		(40	)
Net Loss Attributable from Discontinued Operations to U.S. Global Investors, Inc.														-		(165	)		-		(77	)

Net Income (Loss) Attributable to U.S. Global Investors, Inc.	$	(6,182	)	$	(3,581	)	$	(1,612	)	$	779		$	18,605	$	(4,570	)	$	16,661	$	(1,003	)

Weighted average number of outstanding shares
Basic		15,127,118			15,141,061			15,121,950			15,132,408			15,081,544		15,129,674			15,082,539		15,129,114
Effect of dilutive securities
Employee stock options		-			-			-			-			305		-			404		-
Diluted		15,127,118			15,141,061			15,121,950			15,132,408			15,081,849		15,129,674			15,082,943		15,129,114

Earnings Per Share Attributable to U.S. Global Investors, Inc.
Basic Net Income (Loss) per Share
Income (loss) from continuing operations	$	(0.40	)	$	(0.24	)	$	(0.11	)	$	0.06		$	1.23	$	(0.29	)	$	1.10	$	(0.06	)
Income (loss) from discontinued operations	$	(0.01	)	$	-		$	-		$	(0.01	)
Loss from discontinued operations													$	-	$	(0.01	)	$	-	$	-
Net income (loss)	$	(0.41	)	$	(0.24	)	$	(0.11	)	$	0.05		$	1.23	$	(0.30	)	$	1.10	$	(0.06	)
Diluted Net Income (Loss) per Share
Income (loss) from continuing operations	$	(0.40	)	$	(0.24	)	$	(0.11	)	$	0.06		$	1.23	$	(0.29	)	$	1.10	$	(0.06	)
Income (loss) from discontinued operations	$	(0.01	)	$	-		$	-		$	(0.01	)
Loss from discontinued operations													$	-	$	(0.01	)	$	-	$	-
Net income (loss)	$	(0.41	)	$	(0.24	)	$	(0.11	)	$	0.05		$	1.23	$	(0.30	)	$	1.10	$	(0.06	)

The diluted EPS calculation excludes the effect of stock options when their exercise prices exceed the average market price for the period. For the three and ~~nine~~six months ended ~~March~~December 31, 2020, no employee stock options were excluded from diluted EPS. For the three and six months ended December 31, 2019, employee stock options for 2,000 were excluded from diluted EPS. ~~For the three and nine months ended March 31, 2019, employee stock options for 4,000 were excluded from diluted EPS.~~

During the ~~three and nine~~six months ended ~~March~~December 31, 2020, and 2019, the Company repurchased class A shares on the open market. Upon repurchase, these shares are classified as treasury shares and are deducted from outstanding shares in the earnings per share calculation.

The Company and its non-Canadian subsidiaries file a consolidated U.S. federal income tax return. USCAN and Galileo file separate tax returns in Canada. See income tax information for Galileo in Note 2, Discontinued Operations. Provisions for income taxes include deferred taxes for temporary differences in the bases of assets and liabilities for financial and tax purposes resulting from the use of the liability method of accounting for income taxes.

The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), was signed into law on March 27, 2020. While a number of the CARES Act’s provisions will be reflected in future accounting periods, certain income tax accounting measures are reflected in the period of enactment. The business tax provisions of the Act include temporary changes to income and non-income-based tax laws. Some of the key income tax provisions that may affect the Company include:

~~The Company has reviewed the key income tax provisions of the CARES Act and it appears that they will not materially impact the Company.~~

For U.S. federal income tax purposes at ~~March~~December 31, 2020, the Company has no U.S. federal net operating loss carryovers of $9.0 million with $2.0 million and $2.7 million expiring in fiscal years 2035 and 2036, respectively, and $4.3 million with no expiration. The carryover amount of $4.3 million, which was generated after fiscal year 2018, may be carried forward indefinitely with no limitation on usage prior to fiscal year 2022, but certain limitations apply to the utilization of net operating losses thereafter.carryovers. The Company has capital loss carryovers of ~~$1.1~~$1.0 million with ~~$728,000~~$696,000 and $348,000 expiring in fiscal years 2022 and 2023, respectively. The Company has no charitable contribution carryovers totaling approximately $55,000 with $19,000; $5,000; $10,000; $5,000 and $16,000 expiring in fiscal years 2020, 2021, 2023, 2024, and 2025, respectively. If certain changes in the Company's ownership should occur, there could be an annual limitation on the amount of net operating loss carryovers that could be utilized.at December 31, 2020.

For Canadian income tax purposes, USCAN has ~~total~~no net operating loss carryovers ~~of $81,000 expiring in fiscal year 2040~~ and no capital loss carryovers.

A valuation allowance is provided when it is more likely than not that some portion of the deferred tax amount will not be realized. At ~~March~~December 31, 2020, and June 30, ~~2019,~~2020, a valuation allowance of ~~$3.0 million~~$145,000 and ~~$1.9~~$2.8 million, respectively, was included to fully reserve for net operating loss carryovers, other carryovers and certain book/tax differences in the balance sheet.

The following ~~tables present~~table presents the change in accumulated other comprehensive income (loss) (“AOCI”) by component:

	Nine Months Ended March 31,						Three Months Ended March 31,						Six Months Ended December 31,						Three Months Ended December 31,
(dollars in thousands)	2020			2019			2020			2019			2020			2019			2020		2019
Beginning Balance	$	(206	)	$	1,858		$	(205	)	$	(258	)	$	(4	)	$	(206	)	$	-	$	(219	)
Foreign currency translation adjustment, net of tax ¹		197			1			196			28			12			1			8		14
Reclassification as a result of adoption of accounting guidance ²		-			(2,089	)		-			-
Ending Balance	$	(9	)	$	(230	)	$	(9	)	$	(230	)	$	8		$	(205	)	$	8	$	(205	)

The Company operates principally in two business segments on a continuing operations basis: providing investment management services to USGIF and ETF clients; and investing for its own account in an effort to add growth and value to its cash position. The former segment of investment management services in Canada is discussed in Note 2, Discontinued Operations. The following schedule details total revenues and income for continuing operations by business segment:

(dollars in thousands)	Investment Management Services			Corporate Investments			Consolidated			Investment Management Services			Corporate Investments			Consolidated
Nine months ended March 31, 2020
Six months ended December 31, 2020
Net operating revenues										$	8,410		$	-		$	8,410
Investment income										$	-		$	21,700		$	21,700
Income from equity method investments										$	-		$	484		$	484
Other income										$	59		$	-		$	59
Income from continuing operations before income taxes										$	3,463		$	20,236		$	23,699
Depreciation and amortization										$	98		$	-		$	98
Gross identifiable assets at December 31, 2020										$	8,130		$	34,081		$	42,211
Deferred tax asset																$	-
Consolidated total assets at December 31, 2020																$	42,211
Six months ended December 31, 2019
Net operating revenues	$	2,605		$	-		$	2,605		$	1,691		$	-		$	1,691
Investment loss	$	-		$	(3,922	)	$	(3,922	)	$	-		$	(3,481	)	$	(3,481	)
Loss from equity method investments	$	-		$	(146	)	$	(146	)	$	-		$	(55	)	$	(55	)
Other income	$	90		$	-		$	90		$	61		$	-		$	61
Loss from continuing operations before income taxes	$	(1,884	)	$	(4,252	)	$	(6,136	)	$	(1,000	)	$	(3,654	)	$	(4,654	)
Depreciation and amortization	$	143		$	9		$	152		$	96		$	6		$	102
Gross identifiable assets at March 31, 2020	$	5,240		$	11,479		$	16,719
Total assets held related to discontinued operations							$	-
Deferred tax asset							$	-
Consolidated total assets at March 31, 2020							$	16,719
Nine months ended March 31, 2019
Three months ended December 31, 2020
Net operating revenues										$	5,165		$	-		$	5,165
Investment income										$	-		$	20,702		$	20,702
Income from equity method investments										$	-		$	463		$	463
Other income										$	41		$	-		$	41
Income from continuing operations before income taxes										$	2,461		$	19,264		$	21,725
Depreciation and amortization										$	49		$	-		$	49
Three months ended December 31, 2019
Net operating revenues	$	2,694		$	-		$	2,694		$	887		$	-		$	887
Investment loss	$	-		$	(2,231	)	$	(2,231	)	$	-		$	(451	)	$	(451	)
Loss from equity method investments	$	-		$	(52	)	$	(52	)	$	-		$	(28	)	$	(28	)
Other income	$	27		$	-		$	27		$	39		$	-		$	39
Loss from continuing operations before income taxes	$	(1,837	)	$	(2,395	)	$	(4,232	)	$	(413	)	$	(538	)	$	(951	)
Depreciation and amortization	$	164		$	-		$	164		$	48		$	3		$	51
Three months ended March 31, 2020
Net operating revenues	$	914		$	-		$	914
Investment loss	$	-		$	(441	)	$	(441	)
Loss from equity method investments	$	-		$	(91	)	$	(91	)
Other income	$	29		$	-		$	29
Loss from continuing operations before income taxes	$	(883	)	$	(599	)	$	(1,482	)
Depreciation and amortization	$	47		$	3		$	50
Three months ended March 31, 2019
Net operating revenues	$	857		$	-		$	857
Investment income	$	-		$	2,100		$	2,100
Income from equity method investments	$	-		$	3		$	3
Other income	$	7		$	-		$	7
Income (loss) from continuing operations before income taxes	$	(626	)	$	2,064		$	1,438
Depreciation and amortization	$	54		$	-		$	54

Net operating revenues from investment management services includes operating revenues from USGIF of ~~$713,000~~$1.0 million and ~~$2.2~~$2.0 million ~~respectively,~~ for the three and ~~nine~~six months ended ~~March~~December 31, 2020, respectively, and ~~$720,000~~$754,000 and ~~$2.2~~$1.4 million ~~respectively,~~ for the three and ~~nine~~six months ended ~~March~~December 31, ~~2019.~~2019, respectively. Net operating revenues from investment management services also include operating revenues from ETF clients of ~~$201,000~~$3.6 million and ~~$455,000, respectively,~~$5.9 million for the three and ~~nine~~six months ended ~~March~~December 31, 2020, respectively, and ~~$137,000~~$133,000 and ~~$456,000, respectively,~~254,000 for the three and ~~nine~~six months ended ~~March~~December 31, ~~2019.~~2019, respectively.

The Company continuously reviews ~~all~~ investor, employee, and vendor complaints, and pending or threatened litigation. The likelihood that a loss contingency exists is evaluated through consultation with legal counsel, and a loss contingency is recorded if probable and reasonably estimable.

During the normal course of business, the Company may be subject to claims, legal proceedings, and other contingencies. These matters are subject to various uncertainties, and it is possible that some of these matters may be resolved unfavorably. The Company establishes accruals for matters for which the outcome is probable and can be reasonably estimated. Management believes that any liability in excess of these accruals upon the ultimate resolution of these matters will not have a material adverse effect on the consolidated financial statements of the Company.

~~The~~As of December 31, 2020, the Board has authorized a monthly dividend of $0.0025 per share through ~~June 2020,~~March 2021, at which time it will be considered for continuation by the Board. Payment of cash dividends is within the discretion of the Company’s Board of Directors and is dependent on earnings, operations, capital requirements, general financial condition of the Company, and general business conditions. ~~The~~As of December 31, 2020, the total amount of cash dividends expected to be paid to class A and class C shareholders from ~~April~~January to ~~June 2020~~March 2021 is approximately $113,000. See Note 14 for subsequent change in monthly dividend.

~~See Note 15, Subsequent Events, for a borrowing that was entered into subsequent to March 31, 2020.~~

~~During the quarter ended March 31, 2020, the~~The outbreak of the COVID-19 pandemic and the resulting actions to control or slow the spread has had a significant detrimental effect on the global and domestic economies and financial markets. The Company continues to monitor the impact of COVID-19, but at the date of this report it is too early to determine the full impact this virus may have on the financial markets and economy. Should this emerging macro-economic risk continue for an extended period, there could be an adverse material financial impact to our business and investments, including a material reduction in our results of operations.

~~Effective April 12, 2020,~~In January 2021, the Company ~~was approved~~purchased HIVE convertible securities for $15.0 million. The convertible securities are comprised of 8.0% interest-bearing unsecured convertible debentures with a ~~loan~~principal amount of ~~approximately $442,000 under~~$15.0 million, maturing in five years, and 5 million common share purchase warrants in the ~~Paycheck Protection Program (“PPP”) under~~capital of HIVE. The principal amount of each debenture is convertible into common shares in the ~~CARES Act. The application for this loan required~~capital of HIVE at a conversion rate of $2.34. Each whole warrant, expiring in 36 months, entitles the Company to acquire one common share at a price of $3.00 (Canadian).

In February 2021, the Board authorized an increase in ~~good faith, certify that~~ the ~~current economic uncertainty made~~monthly dividend to $0.0050 per share for February and March 2021, at which time it will be considered for continuation by the ~~loan request necessary to support~~Board. Payment of cash dividends is within the ~~ongoing operations~~discretion of the ~~Company. This certification further requires the Company to take into account its current business activity~~Company’s Board of Directors and its ability to access other sources of liquidity sufficient to support ongoing operations in a manner that is not significantly detrimental to the business. The receipt of these funds, and the forgiveness of the loan attendant to these funds, is dependent on earnings, operations, capital requirements, general financial condition of the Company, ~~having initially qualified for the loan~~ and ~~qualifying for the forgiveness~~general business conditions. The total amount of ~~such loan based on future adherence~~cash dividends expected to ~~the forgiveness criteria as described below.~~be paid to class A and class C shareholders from January to March 2021 is approximately $188,000.

The Company has under 25 employees and is considered a small business. The interest rate on the loan is one percent fixed, and the maturity date is April 12, 2022. Payment terms are to make seventeen consecutive monthly payments of principal and interest in an amount sufficient to fully amortize the loan over the remaining term, commencing six months after the effective date, and a final payment on the earliest of the acceleration of the promissory note; or the maturity date.

~~A key feature of the PPP is that loan proceeds used by borrowers to pay certain expenses during a specified eight-week period (the covered period) are eligible to be forgiven.~~

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

U.S. Global Investors, Inc. (the “Company” or “U.S. Global”) has made forward-looking statements concerning the Company’s performance, financial condition, and operations in this report. The Company from time to time may also make forward-looking statements in its public filings and press releases. Such forward-looking statements are subject to various known and unknown risks and uncertainties and do not guarantee future performance. Actual results could differ materially from those anticipated in such forward-looking statements due to a number of factors, some of which are beyond the Company’s control, including: (i) the volatile and competitive nature of the investment management industry, (ii) changes in domestic and foreign economic conditions, including significant economic disruptions from COVID-19 and the actions taken in connection therewith, (iii) the effect of government regulation on the Company’s business, and (iv) market, credit, and liquidity risks associated with the Company’s investment management activities. Due to such risks, uncertainties, and other factors, the Company cautions each person receiving such forward-looking information not to place undue reliance on such statements. All such forward-looking statements are current only as of the date on which such statements were made.

~~During~~Since the ~~quarter ended March 31,~~beginning of 2020, the rapid spread of the global COVID-19 outbreak and actions taken in response have had a significant detrimental effect on the global and domestic economies and financial markets. Market declines affect the Company’s assets under management, and thus its revenues and also the valuation of the Company’s corporate investments. It is too early to determine the long-term impact of current circumstances on the Company’s business. Should this emerging macro-economic risk continue for an extended period, there could be an adverse material financial impact to the Company’s business and investments, including a material reduction in its results of operations.

COVID-19-related circumstances (e.g., remote work arrangements) have not adversely affected the Company’s ability to maintain operations, including financial reporting systems, internal controls over financial reporting, and disclosure controls and procedures.

The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), was signed into law on March 27, 2020. While a number of the CARES Act’s provisions will be reflected in future accounting periods, certain income tax accounting measures are reflected in the period of enactment. See further information in Note 11, Income Taxes, in the Consolidated Financial Statements of this Quarterly Report on Form 10-Q.

The Company, with principal operations located in San Antonio, Texas, manages two business segments on a continuing operations basis: (1) the Company offers a broad range of investment management products and services to meet the needs of individual and institutional investors, and (2) the Company invests for its own account in an effort to add growth and value to its cash position.

Prior to December 31, 2019, the Company also reported a business segment for investment management services in Canada. The Company, through its Canadian subsidiary U.S. Global Investors (Canada) Limited (“USCAN”), owned a 65 percent controlling interest in Galileo Global Equity Advisors Inc. (“Galileo”), which offers investment management products and services in Canada. USCAN entered into a binding letter of intent dated December 30, 2019, with Galileo whereby Galileo, pursuant to a capital restructuring, agreed to purchase back all of its common shares owned by the USCAN for $1.0 million (Canadian). The transaction was subject to the approval of Canadian securities regulatory authorities and to the satisfaction of other closing conditions. The transaction closed effective March 2, 2020. Proceeds of approximately $746,000 were received (the equivalent of $1.0 million Canadian on the closing date of sale), and a realized gain of $151,000 was recorded. In addition, upon the sale of Galileo, $228,000 in foreign currency losses were released from other comprehensive income (loss) and recorded as realized foreign currency losses. See Note 2, Discontinued Operations, to the Consolidated Financial Statements of this Quarterly Report on Form 10-Q, for further information on the transaction. The Company continued to record its 65 percent interest of Galileo operations through the close of the transaction on March 2, 2020.

The following is a brief discussion of the Company’s business segments included in continuing operations.

The Company generates operating revenues from managing and servicing U.S. Global Investors Funds (“USGIF” or the “Funds”). These revenues are largely dependent on the total value and composition of assets under its management. Fluctuations in the markets and investor sentiment directly impact the asset levels of the Funds, thereby affecting income and results of operations. Detailed information regarding the Funds managed by the Company within USGIF can be found on the Company’s website, www.usfunds.com, including the prospectus and performance information for each Fund. The mutual fund shareholders in USGIF are not required to give advance notice prior to redemption of shares in the Funds.

The Company provides advisory services for two exchange-traded fund (“ETF”) clients and receives monthly advisory fees based on the net asset values of the funds. Information on the ETFs can be found at www.usglobaletfs.com, including the prospectus, performance, and holdings. The ETFs’ authorized participants are not required to give advance notice prior to redemption of shares in the ETFs, and the ETFs do not charge a redemption fee.

At ~~March~~December 31, 2020, total assets under management, including USGIF and ETF clients, were ~~$665.1 million~~approximately $3.5 billion versus ~~$503.8~~$543.6 million at ~~March~~December 31, 2019, an increase of ~~$161.3 million,~~$3.0 billion, or ~~32.0~~550.2 percent. During the ~~nine~~six months ended ~~March~~December 31, 2020, average assets under management, including USGIF and ETF clients, were ~~$518.7 million~~$2.4 billion versus ~~$539.8~~$510.7 million during the ~~nine~~six months ended ~~March~~December 31, 2019. Total assets under management as of period-end at ~~March~~December 31, 2020, including USGIF and ETF clients, were ~~$665.1 million~~$3.5 billion versus ~~$510.1 million~~$1.7 billion at June 30, ~~2019,~~2020, the Company’s prior fiscal year end, an increase of ~~$155.0 million,~~$1.8 billion, or ~~30.4~~106.3 percent.

The increase in assets under management as of ~~March~~December 31, 2020, compared to ~~prior periods~~December 31, 2019, is primarily due to ~~an increase in assets in~~inflows into ETF clients, primarily the U.S. Global Jets ETF (“Jets ETF”) ~~(ticker JETS) that~~. Inflows into the Jets ETF, resulting in an increase in assets, accelerated starting in the latter part of March 2020 and continuing through December 2020. The Jets ETF invests in airline-related stocks, including global airline carriers, airport operators and aircraft manufacturers. While global financial markets have ~~declined,~~experienced declines and volatility, including stocks in which the Jets ETF invests, this ETF has attracted inflows. ~~The increase in assets in Jets ETF in the current period was partially offset by lower assets in USGIF, as noted below.~~

The following tables summarize the changes in assets under management for USGIF for the ~~three and nine~~six months ended ~~March~~December 31, 2020, and 2019:

	Changes in Assets Under Management																		Changes in Assets Under Management
	Nine Months Ended March 31,																		Six Months Ended December 31,
	2020									2019									2020									2019
(dollars in thousands)	Equity			Fixed Income			Total			Equity			Fixed Income			Total			Equity			Fixed Income			Total			Equity			Fixed Income			Total
Beginning Balance	$	334,684		$	90,921		$	425,605		$	389,442		$	106,231		$	495,673		$	343,214		$	82,683		$	425,897		$	334,684		$	90,921		$	425,605
Market appreciation (depreciation)		(65,640	)		898			(64,742	)		(37,113	)		1,272			(35,841	)
Market appreciation																				90,392			355			90,747			43,326			728			44,054
Dividends and distributions		(2,973	)		(829	)		(3,802	)		(20,774	)		(956	)		(21,730	)		(16,243	)		(219	)		(16,462	)		(2,973	)		(603	)		(3,576	)
Net shareholder redemptions		(29,208	)		(9,518	)		(38,726	)		(7,838	)		(11,363	)		(19,201	)
Net shareholder purchases (redemptions)																				10,431			(795	)		9,636			(19,768	)		(5,304	)		(25,072	)
Ending Balance	$	236,863		$	81,472		$	318,335		$	323,717		$	95,184		$	418,901		$	427,794		$	82,024		$	509,818		$	355,269		$	85,742		$	441,011

Average investment management fee		0.97	%		0.01	%		0.77	%		0.97	%		0.01	%		0.75	%		0.90	%		0.01	%		0.74	%		0.97	%		0.02	%		0.77	%
Average net assets	$	329,784		$	87,966		$	417,750		$	338,680		$	99,750		$	438,430		$	395,866		$	84,848		$	480,714		$	336,917		$	89,559		$	426,476

	Changes in Assets Under Management																		Changes in Assets Under Management
	Three Months Ended March 31,																		Three Months Ended December 31,
	2020									2019									2020									2019
(dollars in thousands)	Equity			Fixed Income			Total			Equity			Fixed Income			Total			Equity			Fixed Income			Total			Equity			Fixed Income			Total
Beginning Balance	$	355,269		$	85,742		$	441,011		$	310,164		$	97,204		$	407,368		$	389,485		$	89,373		$	478,858		$	324,644		$	90,400		$	415,044
Market appreciation (depreciation)		(108,964	)		169			(108,795	)		17,781			591			18,372
Market appreciation																				36,724			259			36,983			37,915			331			38,246
Dividends and distributions		-			(226	)		(226	)		-			(330	)		(330	)		(16,242	)		(115	)		(16,357	)		(2,973	)		(295	)		(3,268	)
Net shareholder redemptions		(9,442	)		(4,213	)		(13,655	)		(4,228	)		(2,281	)		(6,509	)
Net shareholder purchases (redemptions)																				17,827			(7,493	)		10,334			(4,317	)		(4,694	)		(9,011	)
Ending Balance	$	236,863		$	81,472		$	318,335		$	323,717		$	95,184		$	418,901		$	427,794		$	82,024		$	509,818		$	355,269		$	85,742		$	441,011

Average investment management fee		0.96	%		0.00	%		0.76	%		0.97	%		0.00	%		0.74	%		0.91	%		0.01	%		0.75	%		0.98	%		0.04	%		0.78	%
Average net assets	$	315,360		$	84,744		$	400,104		$	328,881		$	96,054		$	424,935		$	395,727		$	83,863		$	479,590		$	330,360		$	88,759		$	419,119

As shown above, USGIF period-end assets under management were ~~lower~~higher at ~~March~~December 31, 2020, compared to ~~March~~December 31, 2019. Average net assets for the three and six months in the current fiscal year were higher than the same periods in the previous fiscal year for equity funds and in total, while average net assets for fixed income funds were lower than the same periods in the ~~previous~~prior fiscal year. The three and ~~nine~~six months ended ~~March~~December 31, 2020, and ~~the nine months ended March 31,~~ 2019, had net market ~~depreciation~~appreciation in the equity funds, primarily in the gold and ~~resource funds. The three months ended March 31, 2019, had net market appreciation across all equity~~natural resources funds. There was also net market appreciation in the fixed income funds for ~~all~~both periods. A significant portion of the dividends and distributions shown above were reinvested and included in net shareholder ~~redemptions. The combined amounts~~purchases (redemptions). There were net shareholder purchases for ~~these two lines~~the equity funds and net shareholder redemptions for ~~all periods shown~~the fixed income funds for the three and six months ended December 31, 2020. There were ~~negative.~~net shareholder redemptions for both equity and fixed income funds for the three and six months ended December 31, 2019.

The average annualized investment management fee rate (total advisory fees, excluding performance fees, as a percentage of average assets under management) was 7674 and 7775 basis points for the three and ~~nine~~six months ended ~~March~~December 31, 2020, respectively, and 7477 and 7578 basis points for the same periods in the prior year. The average investment management fee for the equity funds was 9690 and 9791 basis points for the three and ~~nine~~six months ended ~~March~~December 31, 2020, and 97 and 98 basis points for the same periods in the prior year. The Company has agreed to contractually or voluntarily limit the expenses of the Funds. Therefore, the Company waived or reduced its fees and/or agreed to pay expenses of the Funds. ~~Due~~The decline in the average investment management fee rate for the equity funds was due to fee waivers. Also, due to fee waivers, the average investment management fee for the fixed income funds was ~~0 and~~ 1 basis point for the three and ~~nine~~six months ended ~~March~~December 31, 2020, and 02 and 14 basis ~~point~~points for the same periods in the prior year, respectively.

Management believes it can more effectively manage the Company’s cash position by broadening the types of investments used in cash management and continues to believe that such activities are in the best interest of the Company. The Company’s investment activities are reviewed and monitored by Company compliance personnel, and various reports are provided to certain investment advisory clients. Written procedures are in place to manage compliance with the code of ethics and other policies affecting the Company’s investment practices. This source of revenue does not remain consistent and is dependent on market fluctuations, the Company’s ability to participate in investment opportunities, and timing of transactions.

As of ~~March~~December 31, 2020, the Company held investments with a fair value of approximately ~~$9.5~~$12.5 million and a cost basis of approximately ~~$12.9~~$10.6 million. The fair value of these investments is ~~56.7~~29.6 percent of the Company’s total assets. In addition, the Company held other investments which do not have readily determinable fair values of approximately ~~$1.5~~$1.4 million, investments in held-to-maturity securities of $1.0 million, and ~~$150,000 in~~ investments accounted for under the equity method of ~~accounting.~~accounting of $654,000.

Investments recorded at fair value were approximately ~~$9.5~~$12.5 million at ~~March~~December 31, 2020, compared to approximately ~~$15.2~~$11.5 million at June 30, ~~2019,~~2020, the Company’s prior fiscal year end, which is ~~a decrease~~an increase of approximately ~~$5.7~~$1.0 million. See Note 3, Investments, to the Consolidated Financial Statements of this Quarterly Report on Form 10-Q, for further information regarding investment activities.

RESULTS OF OPERATIONS – Three months ended ~~March~~31December 31, 2020, and 2019

The Company posted net income attributable to U.S. Global Investors, Inc. of $16.7 million ($1.10 per share) for the three months ended December 31, 2020, compared with a net loss attributable to U.S. Global Investors, Inc. of ~~$1.6~~$1.0 million ($~~0.11~~0.06 per share loss) for the three months ended ~~March 31, 2020, compared with net income attributable to U.S. Global Investors, Inc. of $779,000 ($0.05 per share) for the three months ended March~~December 31, 2019, a ~~negative~~positive change of approximately ~~$2.4~~$17.7 million. The change is primarily due to operating income and realized and unrealized investment ~~losses~~gains in the current quarter compared to operating loss and unrealized investment ~~gains~~losses in the same quarter last year, as discussed further below.

Total consolidated operating revenues for the three months ended ~~March~~December 31, 2020, increased ~~$57,000,~~$4.3 million, or ~~6.7~~482.3 percent, compared with the three months ended ~~March~~December 31, 2019. This increase was primarily attributable to the following:

Total consolidated operating expenses for the three months ended ~~March~~December 31, 2020, increased ~~$364,000,~~$3.2 million, or ~~23.8~~232.3 percent, compared with the three months ended ~~March~~December 31, 2019. The increase in operating expenses was primarily attributable to an increase in employee compensation of $2.6 million, or 411.5 percent, primarily due to increased bonuses related to realized investment gains and an increase in general and administrative expenses of ~~$338,000,~~$629,000, or ~~44.9~~94.9 percent, primarily due to higher ETF expenses and business development costs related to the increase in ETF ~~assets during the current quarter.~~assets.

Total consolidated other ~~loss~~income for the three months ended ~~March~~December 31, 2020, was ~~($503,000),~~$21.2 million, compared to total other ~~income~~loss of ~~$2.1 million~~$440,000 for the three months ended ~~March~~December 31, 2019, a ~~decrease~~positive change of ~~$2.6 million, or 123.8 percent.~~$21.6 million. This change was primarily due to the following factors:

A tax expense from continuing operations of ~~$75,000~~$5.1 million was recorded for the three months ended ~~March~~December 31, 2020, compared to tax ~~expense~~benefit of ~~$546,000~~$25,000 for the three months ended ~~March~~December 31, 2019. Note that the Company currently has net operating loss carryovers in certain jurisdictions, including the United States. A valuation allowance has been recorded to fully reserve for net operating loss carryovers, other carryovers and certain book/tax differences in the balance sheet. The tax expense in the current quarter iswas primarily the result of ~~increasing the valuation allowance to fully reserve for deferred tax assets, while the tax expense in the same quarter in the prior year was primarily the result~~realized gains on sales of securities and an increase in valuation of certain investments held by USCAN, which increased the related deferred tax liability. The tax benefit in the same quarter in the prior year was primarily the result of a decrease in valuation of certain investments held by USCAN, which decreased the related deferred tax liability.

Income (loss) from discontinued operations represents results of the Company’s subsidiary Galileo, which was sold on March 2, 2020. Loss from discontinued operations, net of tax, was ~~$85,000 and $174,000~~$117,000 for the three months ended ~~March~~December 31, 2020, and 2019, respectively. Revenue from base advisory fees was lower in the current period due to the closure in July 2019 of one of the mutual funds managed by Galileo, the closure in September 2019 of the ETF managed by Galileo, and the current period including only two months of revenue prior to closing of the sale. There were no performance fees for Galileo clients received in either the current or prior periods. The decrease in revenue from the prior period was somewhat offset by lower expenses, primarily due to lower fund expenses, lower compensation due to a decrease in employees, and the current period including only two months of expenses prior to closing of the sale.2019. See Note 2, Discontinued Operations, to the Consolidated Financial Statements of this Quarterly Report on Form 10-Q for further information on this transaction and the results from Galileo operations.

RESULTS OF OPERATIONS – ~~Nine~~Six months ended ~~March~~31~~, 20~~20,December 31, 2020, and ~~201~~9 2019

The Company posted a net ~~loss~~income attributable to U.S. Global Investors, Inc. of ~~$6.2~~$18.6 million ($~~0.41 loss~~1.23 per share) for the ~~nine~~six months ended ~~March~~December 31, 2020, compared to a net loss attributable to U.S. Global Investors, Inc. of ~~$3.6~~$4.6 million ($~~0.24~~0.30 loss per share) for the ~~nine~~six months ended ~~March~~December 31, 2019, ~~an increase in loss~~a positive change of approximately ~~$2.6~~$23.2 million. The ~~increase in loss~~change is primarily due to ~~an increase~~operating income and realized and unrealized investment gains in the current quarter compared to operating loss and unrealized investment losses ~~and losses from discontinued operations,~~in the same period last year, as discussed further below.

Total consolidated operating revenues for the ~~nine~~six months ended ~~March~~December 31, 2020, ~~decreased $89,000,~~increased $6.7 million, or ~~3.3~~397.3 percent, compared with the ~~nine~~six months ended ~~March~~December 31, 2019. This ~~decrease~~increase was primarily attributable to the following:

Total consolidated operating expenses for the ~~nine~~six months ended ~~March~~December 31, 2020, increased ~~$93,000,~~$4.1 million, or ~~2.0~~142.3 percent, compared with the ~~nine~~six months ended ~~March~~December 31, 2019. The increase in operating expenses was primarily attributable to an increase in employee compensation of $2.9 million, or 212.3 percent, primarily due to increased bonuses related to realized investment gains and positive fund performance and an increase in general and administrative expenses of ~~$206,000,~~$1.2 million, or ~~9.2~~88.1 percent, primarily due to higher ETF expenses and business development costs related to the increase in ETF ~~assets during the current quarter. This increase was somewhat offset by a decrease in employee compensation and benefits expenses of $90,000, or 4.2 percent, primarily due to lower salary expense.~~assets.

Total consolidated other income (loss) for the six months ended December 31, 2020, increased $25.7 million, compared with other loss for the ~~nine~~six months ended ~~March 31, 2020, increased $1.7 million, or 76.3 percent, compared with the nine months ended March~~December 31, 2019. The ~~increase in loss~~positive change was primarily due to the following factors:

A tax ~~benefit~~expense from continuing operations of ~~$174,000~~$5.1 million was recorded for the ~~nine~~six months ended ~~March~~December 31, 2020, compared to a tax benefit of ~~$554,000~~$249,000 for the ~~nine~~six months ended ~~March~~December 31, 2019. Note that the Company currently has net operating loss carryovers in certain jurisdictions, including the United States. A valuation allowance has been recorded to fully reserve for net operating loss carryovers, other carryovers and certain book/The tax ~~differences~~expense in the ~~balance sheet. The tax benefit in the both periods~~current quarter was primarily the result of ~~decreases~~realized gain on sale of securities and an increase in valuation of certain investments held by USCAN, which ~~reduced~~increased the related deferred tax liability. The tax benefit in the same period in the prior year was primarily the result of a decrease in valuation of certain investments held by USCAN, which decreased the related deferred tax liability.

Income (loss) from discontinued operations represents results of the Company’s subsidiary Galileo, which was sold on March 2, 2020. Loss from discontinued operations, net of tax, was $253,000 for the ~~nine~~six months ended ~~March~~December 31, 2020, was $338,000, compared to net income from discontinued operations, net of tax, for the nine months ended March 31, 2019, of $149,000. Revenue from base advisory fees was lower in the current period due to the closure in July 2019 of one of the mutual funds managed by Galileo, the closure in September 2019 of the ETF managed by Galileo, and the current period including only eight months of revenue prior to closing of the sale. There were no performance fees for Galileo clients received in the current period compared to $870,000 received in the corresponding period in the prior year, decreasing revenue by $870,000. Galileo received performance fees from certain clients when market appreciation or realized net gains exceeded established benchmarks. The decrease in revenue from the prior period was somewhat offset by lower expenses, primarily due to lower fund expenses, lower compensation due to a decrease in employees, and the current period including only eight months of expenses prior to closing of the sale.2019. See Note 2, Discontinued Operations, to the Consolidated Financial Statements of this Quarterly Report on Form 10-Q for further information on this transaction and the results from Galileo operations.

At ~~March~~December 31, 2020, and after including the subsequent investment purchase of HIVE, the Company had net working capital (current assets minus current liabilities) of approximately ~~$8.8~~$10.3 million and a current ratio (current assets divided by current liabilities) of ~~7.5~~2.7 to 1. With approximately ~~$2.1~~$6.6 million in cash and cash equivalents, after including the subsequent investment purchase of HIVE, and approximately ~~$9.3~~$12.5 million in ~~unrestricted~~ securities at fair value, the Company has adequate liquidity to meet its current obligations. ~~Total U.S. Global Investors, Inc. shareholders’ equity is approximately $15.3 million, with cash, cash equivalents, and unrestricted marketable securities comprising 67.9 percent of total assets.~~

Effective April 12, 2020, the Company was approved for a loan of approximately $442,000 under the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”). The Company has under 25 employees and is considered a small business. The interest rate on the loan is one percent fixed, and the maturity date is April 12, 2022. Payment terms are to make seventeen consecutive monthly payments of principal and interest in an amount sufficient to fully amortize the loan over the remaining term, commencing six months after the effective date, and a final payment on the earliestCompany has been granted forgiveness of the ~~acceleration of the promissory note; or the maturity date.~~entire PPP loan and any accrued interest.

~~A key feature of the PPP is that loan proceeds used by borrowers to pay certain expenses during a specified eight-week period (the covered period) are eligible to be forgiven.~~

~~Except for the loan received in April 2020, the Company has no borrowings or long-term liabilities except for lease obligations.~~ The Company also has access to a $1 million credit facility for working capital purposes. The credit agreement requires the Company to maintain certain covenants; the Company has been in compliance with these covenants during the current fiscal year. The credit agreement will expire on May 31, ~~2020,~~2021, and the Company intends to renew annually. The credit facility is collateralized by $1 million at ~~March~~December 31, 2020, held in deposit in a money market account at the financial institution that provided the credit facility. As of ~~March~~December 31, 2020, the credit facility remains unutilized by the Company.

The ~~effects~~rapid spread of the global COVID-19 ~~pandemic are still evolving. There has been an adverse~~outbreak and actions taken in response have had a significant detrimental effect on the global and domestic economies and financial ~~markets, which adversely affects~~markets. Market declines affect the Company’s assets under management, and thus ~~revenue~~its revenues and also the valuation of the Company’s corporate investments. It is early to determine the long-term impact of current circumstances on the Company’s business. Should this emerging macro-economic risk continue for an extended period, there could be an adverse material financial impact to ~~our~~the Company’s business and investments, including a material reduction in ~~our~~its results of operations.

The investment advisory and administrative services contracts between the Company and USGIF have been renewed through September ~~2020,~~2021, and management anticipates that the contracts will be renewed. The investment advisory contracts between the Company and the ETFs expire in September ~~2020,~~2021, and management anticipates that the contracts will be renewed.

The primary cash requirements are for operating activities. The Company also uses cash to purchase investments, pay dividends and repurchase Company stock. The cash outlays for investments and dividend payments are discretionary, and management or the Board may discontinue as deemed necessary. The stock repurchase plan is approved through December 31, ~~2020,~~2021, but may be suspended or discontinued at any time. Cash, after subsequent investment purchase of HIVE, and ~~unrestricted~~ marketable securities of approximately ~~$11.4~~$19.1 million are available to fund current activities. Management believes current cash reserves, investments, and financing available will be sufficient to meet foreseeable cash needs for operating activities.

For a discussion of other critical accounting policies that the Company follows, please refer to the notes to the consolidated financial statements included in the Annual Report on Form 10-K for the year ended June 30, ~~2019.~~2020.

The effects of the global COVID-19 pandemic are still evolving. There has been an adverse effect on global and domestic financial markets, which may continue for an undetermined period. This may adversely affect assets under management and thus the Company’s revenues and operating results. Market declines also affect the valuation of the Company’s corporate investments, which also adversely affects the Company’s balance sheet and results of operations.

Revenues are generally based upon a percentage of the market value of assets under management in accordance with contractual agreements. Accordingly, fluctuations in the financial markets have a direct effect on the Company’s operating results. A significant portion of assets under management in equity funds have exposure to international markets and/or natural resource sectors, which may experience volatility. In addition, fluctuations in interest rates may affect the value of assets under management in fixed income funds.

USGIF advisory fees are comprised of two components: a base management fee and a performance fee. The performance fee is a fulcrum fee that is adjusted upwards or downwards by 0.25 percent when there is a performance difference of 5 percent or more between a fund’s performance and that of its designated benchmark index over the prior rolling 12 months.

As a result, the Company’s revenues are subject to volatility beyond market-based fluctuations discussed in the investment management and administrative services fees section above. For the three and ~~nine~~six months ended ~~March~~December 31, 2020, the Company realized ~~a decrease~~an increase in its USGIF base advisory fee of ~~$79,000~~$115,000 and ~~$391,000,~~$124,000, respectively, due to these performance adjustments. For the three and ~~nine~~six months ended ~~March~~December 31, 2019, the Company realized a decrease in its USGIF base advisory fee of ~~$110,000~~$115,000 and ~~$372,000,~~$312,000, respectively, due to these performance adjustments.

The Company’s Consolidated Balance Sheets includes assets whose fair value is subject to market risks. Due to the Company’s investments in securities recorded at fair value, price fluctuations represent a market risk factor affecting the Company’s consolidated financial position. The carrying values of investments subject to price risks are based on quoted market prices or, if not actively traded, management’s estimate of fair value as of the balance sheet date. Market prices fluctuate, and the amount realized in the subsequent sale of an investment may differ significantly from the reported market value.

The Company’s investment activities are reviewed and monitored by Company compliance personnel, and various reports are provided to certain investment advisory clients. Written procedures are in place to manage compliance with the code of ethics and other policies affecting the Company’s investment practices.

The table below summarizes the Company’s price risks in securities recorded at fair value as of ~~March~~December 31, 2020, and shows the effects of a hypothetical 25 percent increase and a 25 percent decrease in market prices.

(dollars in thousands)

Fair Value at

March 31, 2020

Hypothetical Percentage Change

Estimated Fair Value After Hypothetical Price Change

Fair Value at

December 31, 2020

Hypothetical Percentage Change

Estimated Fair Value After Hypothetical Price Change

Securities at fair value ¹

9,480

25% increase

11,850

12,494

25% increase

15,618

25% decrease

7,110

25% decrease

9,371

The selected hypothetical changes do not reflect what could be considered best- or worst-case scenarios. Results could be significantly different due to both the nature of markets and the concentration of the Company’s investment portfolio.

The effects of the global COVID-19 pandemic are still evolving. There has been an adverse effect on global and domestic financial markets, which may continue for an undetermined period. This not only adversely affects the Company’s assets under management but also the valuation of the Company’s corporate investments.

A significant portion of securities at fair value in the above table is an investment in HIVE Blockchain Technologies Ltd. (“HIVE”), which was valued at approximately $1.3 million at March 31, 2020. HIVE is discussed in more detail in Note 3, Investments, to the Consolidated Financial Statements of this Quarterly Report on Form 10-Q. HIVE is a company that is headquartered and traded in Canada with cryptocurrency mining facilities in Iceland and Sweden. Cryptocurrency markets and related stocks have been, and are expected to continue to be, volatile. Cryptocurrency mining is still considered an early stage high-risk industry, and the nature of mining is expected to evolve. There is potential for significant continued volatility in the market price of HIVE, which could materially impact the investment’s value included on the balance sheet and unrealized gain (loss) recognized in investment income.

~~In addition to the securities at fair value shown in the table above, the~~The Company also has an equity method investment in Galileo ~~Technology and Blockchain~~New Economy Fund LP ~~valued~~in the amount of $654,000 at ~~approximately $150,000 as of March~~December 31, 2020. As discussed further in Note 3, Investments, to the Consolidated Financial Statements of this Quarterly Report on Form 10-Q, the Galileo Technology and Blockchain LP, a Canadian limited partnership managed by Galileo,2020, which has investments ~~concentrated~~ in the technology and cryptocurrency mining ~~stocks.~~industries. As noted above, exposure to ~~the~~ cryptocurrency industry may result in volatility in the valuation of this ~~investment.~~fund. Under the equity method, the Company’s proportional share of the ~~LP’s~~fund’s net income or loss, which primarily consists of realized and unrealized gains and losses on investments offset by fund expenses, is recognized in the Company’s earnings. The potential significant volatility in the valuation of the ~~LP’s~~fund’s investments could cause the ~~its~~fund’s net income or loss to vary significantly from period to period, which in turn would be reflected in the Company’s earnings.

A portion of cash and certain corporate investments, including the Company’s equity method investment, are held in foreign currencies, primarily Canadian. Adverse changes in foreign currency exchange rates would lower the value of those cash accounts and corporate investments. Certain assets under management also have exposure to foreign currency fluctuations in various markets, which could impact their valuation and thus the revenue received by the Company.

An evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of ~~March~~December 31, 2020, was conducted under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective as of ~~March~~December 31, 2020.

There has been no change in the Company’s internal control over financial reporting that occurred during the three months ended ~~March~~December 31, 2020, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

~~The following modifications to risk factors is intended to supplement and should be read along with the~~For a discussion of ~~other~~ risk factors which could affect the Company, ~~included in~~please refer to Item 1A, “Risk Factors” in the Annual Report on Form 10-K for the year ended June 30, ~~2019.~~

~~Natural disasters, global pandemics and other unpredictable events could adversely affect our operations.~~

~~Natural disasters, outbreaks of epidemics, terrorist attacks, extreme weather events or other unpredictable events could adversely affect our revenues, expenses, and net income by:~~

The Company’s business operations are concentrated in San Antonio, Texas. The Company has developed various backup systems and contingency plans but cannot be assured that those preparations will be adequate in all circumstances that could arise, or that2020. There have been no material ~~interruptions and disruptions will not occur. The Company also relies~~changes since fiscal year end to ~~varying degrees on outside vendors for service delivery in addition to technology and disaster contingency support, and there is a~~the risk that these vendors will not be able to perform in an adequate and timely manner. If the Company loses the availability of employees, or if it is unable to respond adequately to such an event in a timely manner, revenues, expenses, and net income could be negatively impacted.factors listed therein.

Specifically, the effects of the outbreak of the novel coronavirus (COVID-19) since December 2019 have negatively affected the global economy, the United States economy and the global financial markets, and may disrupt the Company’s operations and the Company’s clients' operations, which could have an adverse effect on the Company’s business, financial condition and results of operations. Although the long-term effects of the current pandemic cannot currently be predicted, previous occurrences of other pandemic and epidemic diseases had an adverse effect on the economies of those countries in which they were most prevalent. A recurrence of an outbreak of any kind of epidemic, communicable disease or virus or major public health issue could cause a slowdown in the levels of economic activity generally, which would adversely affect the Company’s business, financial condition and operations

(dollars in thousands, except price data)	(dollars in thousands, except price data)											(dollars in thousands, except price data)
Period		Total Number of Shares Purchased¹		Total Amount Purchased		Average Price Paid Per Share²		Total Number of Shares Purchased as Part of Publicly Announced Plan³		Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan			Total Number of Shares Purchased ¹		Total Amount Purchased		Average Price Paid Per Share ²		Total Number of Shares Purchased as Part of Publicly Announced Plan ³		Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan
01-01-20 to 01-31-20			-	$	-	$	-		-	$	2,750
02-01-20 to 02-29-20			1,000		1	$	1.30		1,000	$	2,749
03-01-20 to 03-31-20			68,420		67	$	0.98		68,420	$	2,682
10-01-20 to 10-31-20														-	$	-	$	-		-	$	2,643
11-01-20 to 11-30-20														3,472		10	$	3.03		3,472	$	2,633
12-01-20 to 12-31-20														11,624		50	$	4.28		11,624	$	2,583
Total			69,420	$	68	$	0.98		69,420					15,096	$	60	$	3.99		15,096

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereto duly authorized.

Texas	74-1598370
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

7900 Callaghan Road San Antonio, Texas	78229 (Zip Code)
(Address of principal executive offices)

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☐



PART I. FINANCIAL INFORMATION	1

ITEM 1. FINANCIAL STATEMENTS	1
CONSOLIDATED BALANCE SHEETS	1
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)	2
CONSOLIDATED STATEMENTS COMPREHENSIVE INCOME (LOSS) (UNAUDITED)	3
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED)	4
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)	6
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)	7
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	2220
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	287
ITEM 4. CONTROLS AND PROCEDURES	298

PART II. OTHER INFORMATION	3029

ITEM 1A. RISK FACTORS	3029
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	3029
ITEM 6. EXHIBITS	3130

SIGNATURES	3231

		•	Base management fees ~~decreased $57,000.~~increased $5.8 million. The majority of this increase was from ETF unitary management fees, which increased $5.7 million as the result of an increase in ETF average assets under management, primarily for the Jets ETF. Inflows into the Jets ETF accelerated starting in the latter part of March 2020 and continuing through December 2020, resulting in an increase in assets. The Jets ETF invests in airline-related stocks, including global airline carriers, airport operators and aircraft manufacturers. While global financial markets have experienced declines and volatility, including stocks in which the Jets ETF invests, this ETF has attracted inflows. Base fees for USGIF ~~decreased $56,000~~increased by $143,000, primarily as a result of ~~lower~~higher average assets under management due to market ~~depreciation and shareholder redemptions. ETF unitary management fees decreased $1,000 and thus were basically flat.~~appreciation.
		•	Performance fees for USGIF ~~paid out~~received in the current period were ~~$391,000~~$124,000 compared to ~~$372,000~~$312,000 in fees paid out in the corresponding period in the prior year, a ~~negative~~positive change of ~~$19,000.~~$436,000. The performance fee, which applies to the USGIF equity funds only, is a fulcrum fee that is adjusted upwards or downwards by 0.25 percent when there is a performance difference of 5 percent or more between a fund’s performance and that of its designated benchmark index over the prior rolling 12 months.

1. Exhibits –
31.1	Rule 13a-14(a) Certifications (under Section 302 of the Sarbanes-Oxley Act of 2002), included herein.
32.1	Section 1350 Certifications (under Section 906 of the Sarbanes-Oxley Act Of 2002), included herein.

101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Labels Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

		U.S. GLOBAL INVESTORS, INC.

DATED:	~~May 14, 2020~~February 4, 2021	BY: /s/ Frank E. Holmes
		Frank E. Holmes
		Chief Executive Officer

DATED:	~~May 14, 2020~~February 4, 2021	BY: /s/ Lisa C. Callicotte
		Lisa C. Callicotte
		Chief Financial Officer